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ABSTRACT 
 We previously proposed that colonizing strains of E. coli likely occupy 
specific niches as minimal members of mixed biofilms formed primarily by anaerobic 
members of the gut flora.  These “restaurants” formed by the different community 
members of the gut provide individual strains of E. coli with various unique binding 
pockets and locally provided mono- and disaccharides by breaking down 
polysaccharides which facultative anaerobes, such as E. coli, could not break down on 
their own.  This allows strains of E. coli that cannot grow as efficiently on available 
sugars to colonize if they are able to occupy niches that other competing strains could 
not.  For example, if the less efficient strain could bind better to specific anaerobic 
members or had a higher tolerance for bile salts it would be able to co-colonize with a 
strain that could grow better on available sugars as it would not be in direct 
competition to occupy the same niche.  While the anaerobes in mixed biofilms provide 
a source of nutrients for minimal members such as E. coli through breakdown of large 
polysaccharides, the facultative anaerobes may improve the environment for strict 
anaerobes by reducing the concentration of oxygen within the biofilms.  Oxygen 
diffuses from surrounding tissue into the intestines, oxygen from swallowed air is 
present in flatus, and at least one predominant anaerobe in the gut microbiome, 
Bacteroides fragilis, respires oxygen at low concentrations.  As such, manuscript I 
looks at how colonization with specific strains of E. coli can affect the development of 
the intestinal microbiota.  Five representative E. coli strains were used for this study: 
Nissle 1917, EDL933, MG1655, and two MG1655 mutants selected by the mouse gut 
(envZ P41L and flhDC).  While slight variances were observed between strains, these 
  
were likely due to differences between hosts rather than the colonizing E. coli and no 
significant differences between the communities could be surmised. 
 In order to better understand the interactions between E. coli and the members 
of the intestinal microbiota, a novel in vitro method was developed.  Manuscript II 
examines the development of the in vitro system as it was compared to the mouse 
model.  This method was designed to be simple and inexpensive while providing an 
environment meant to replicate the natural habitat of these organisms: the mammalian 
gut.  The current study examines the development of said in vitro model and its ability 
to mimic the mouse gut in terms of diversity of organisms, as well as its usefulness in 
examining the colonizing ability of competing E. coli strains.  It is shown that, while 
still in development, this system is currently able to maintain diversity comparable to 
what is seen in mice.  While the abundance of these diverse organisms is not 
necessarily at the levels seen in mice, the model is already an effective system for 
studying the microbial community of the gut in a controlled environment.  
Furthermore, the system is able to mimic certain colonization experiments of 
competing E. coli strains done in mice, and with improvements to bolster the growth 
of the diverse population could be used as a non-invasive method for studying gut 
microbes. 
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PREFACE 
This dissertation has been prepared in the Manuscript Format according to the 
guidelines of the Graduate School of the University of Rhode Island with the style 
presented in the American Society for Microbiology journal, Infection and Immunity.  
The dissertation includes an introduction and the following two manuscripts: 
The first manuscript: “Analysis of how Different Strains of Escherichia coli 
Affect Development of the Intestinal Microbiota” 
The second manuscript: “Developing an In Vitro Method for Studying the 
Interaction between E. coli and the Intestinal Microbiota” 
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LITERATURE REVIEW 
Introduction 
The human intestinal tract is known to maintain a diverse population of 
microorganisms represented by both anaerobic and facultative anaerobic species (10).  
It is well known that commensal strains of E. coli colonize as a minority member of 
these communities as a facultative anaerobe (22).  Commensal strains include 
organisms that naturally inhabit a host organism’s body without causing harm, and in 
some cases even providing the host with a particular advantage (21).  In contrast, a 
pathogenic strain is usually an invasive organism that may be of the same species, 
such as E. coli EDL933, but disease is caused rather than a harmless coexistence (21). 
From ingestion to colonization 
When a host ingests E. coli from the environment the E. coli must be able to 
pass the acid barrier of the stomach, as well as be able to attain the nutrients necessary 
to begin logarithmic growth.  As stationary phase bacteria are acid-tolerant (14), as 
few as 10 E. coli cells can lead to transmission (24).  In order to exit lag phase and 
begin logarithmic growth upon reaching the colon, E. coli must compete for nutrients 
with a dense community (15), be able to penetrate into the mucus layer (31), and grow 
rapidly enough to make up for the constant turnover of the mucus layer (37) all while 
avoiding host defenses (7, 29).  When successful in colonizing the colon, some E. coli 
cells are still removed with the turnover of mucus.  These cells are able to re-enter the 
environment where they can be ingested by the next host, and thus spread and 
continue to exist (34, 35). 
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Basic principles of colonization 
According to Freter’s nutrient-niche hypothesis, colonizing strains can coexist 
as long as they are able to outcompete one another on one or more sugars, or are able 
to bind to the intestinal wall.  Thus if two strains (X and Y) are in direct competition 
and (X) can utilize all sugars better than (Y), then the less efficient strain (Y) cannot 
co-colonize (11).  This hypothesis assumes that all available nutrients are 
homogenized, or equally mixed, throughout the intestine (15).  As such, a diverse and 
stable community would hinder invading species and prevent them from colonizing.  
This ability to prevent invasion from outside species is called “colonization resistance” 
(41).  Even with this in mind, E. coli strains can coexist due to diverse strategies for 
the utilization of limited nutrients within the colon. 
Central metabolism and intestinal colonization 
E. coli is a Gram-negative, prototrophic, facultative anaerobe.  While E. coli 
grows best on sugars it cannot grow on larger polysaccharides, as it does not have the 
enzymes available to do so (12).  It can also grow on substrates that feed into the TCA 
cycle, which require gluconeogenesis to metabolize.  Other important central 
metabolism pathways in E. coli include the Embden-Meyerhof-Parnas glycolytic 
pathway (EMP), the pentose phosphate pathway (PP), the Entner-Duodoroff pathway 
(ED), and many fermentation pathways all of which are highly conserved (9). 
Catabolic pathway diversity in E. coli 
While the central metabolism genes are highly conserved across strains of E. 
coli, there is variation between strains in terms of the catabolic pathways that feed into 
these core central metabolism pathways (9, 32).  In other words, some E. coli strains 
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have different preferences in terms of growth on sugars or other substrates.  It has 
been shown that while E. coli strains have similar catabolic potential, the sugars each 
strain uses to support their colonization differs significantly (5, 8, 12, 20, 28, 30, 39). 
Nutrient availability in the intestine 
Mucus in the gut exists in two forms, the loose layer and the firm layer (19).  
The loose mucus layer is where most of the microbiota of the gut grow and form their 
biofilms, while the firm mucus layer resides closer to the epithelial layer of the 
intestines and prevents direct interaction of the commensal microbiota with host 
epithelium (19).  The mucus itself consists of a large mixture of molecules, including 
but not limited to amino acids, large polysaccharides, mono- and disaccharides, and 
mucin (4).  This mixture exists as a viscous liquid in which the microbes are 
suspended and in which form biofilms.  This environment is mostly anaerobic, with 
minimal oxygen leaking from epithelial cells of the intestine (6, 16, 18, 23).  Mucin is 
a glycoprotein with large polysaccharide strands with which the anaerobe populations 
of the gut can attach and form biofilms around (2).  The biofilms formed by these 
anaerobes can break down the large polysaccharides of the mucus, and parts of the 
mucin, thus providing facultatives with usable mono- and disaccharides in bulk which 
would usually be limited (22, 33, 40).  This gives facultatives, such as E. coli, a reason 
for joining as minimal members in these anaerobe-formed biofilms, and perhaps even 
promoting the growth of preferential anaerobes that provide specific mono- and 
disaccharides (18).  The facultatives that join these mixed biofilms likely provide the 
anaerobes with protection from the minimal amount of oxygen that is released from 
the epithelial tissue of the gut. 
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Competition for limited nutrients in the intestine 
In order to compete for limiting resources in the intestine, E. coli is able to 
expand their transcriptome in order to induce a broad set of gene systems used for 
carbon-source transport and catabolism (17).  Additionally, it has been shown that 
glycogen stores are used for survival during times of carbon limitation and are also 
important for colonizing E. coli strains when colonizing the intestine (20).  By 
expanding the gene systems used for carbon-source transport and catabolism, E. coli is 
able to use a diverse set of sugars and can use nutrients that are available which no 
other member of the microbiota has used.  A specific E. coli strain can also 
outcompete other strains by growing faster on the available nutrients (13).  
Furthermore, if an E. coli strain is being outcompeted for its preferred nutrients it will 
activate other mechanisms in which it is no longer in direct competition (i.e. switching 
to use other available sugars or pathways such as gluconeogenesis) (3, 5, 28, 38).  
Finally, if a strain is able to enter a niche in which it forms a symbiotic relationship 
(i.e. in a mixed anaerobic biofilm) that provides its preferred sugar(s), it will be able to 
colonize away from direct competition with faster growing strains (1, 22). 
Biofilms in the intestine 
It has been shown that biofilms form in the mucus layers of the large intestines 
of healthy mammals (25, 26, 33, 40).  Furthermore, biofilms containing Bacteroides, 
Enterobacter, and Clostridia species found in the intestine can form rapidly on mucin 
in continuous flow culture systems developed to mimic the human intestine (27), thus 
being able to develop faster than the flow of mucus (36).  Recent studies of these 
bacterial biofilms in the intestines have shown that anaerobes form dense biofilms 
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with E.coli as a minority member (22).  These biofilms form around intestinal mucin 
and break down large polysaccharides, such as fiber, that cannot usually be utilized by 
facultative anaerobes (22, 33, 40).  Differences in the population of anaerobes within 
mixed biofilms would thus provide E. coli with various niches based on nutrients 
made available by the anaerobes preferred metabolic pathways.   
The “restaurant” hypothesis 
Our laboratory previously proposed an adjustment to the Freter’s hypothesis 
which states that the mono- and disaccharides that E. coli strains use for growth in the 
intestine are made available locally from polysaccharide degradation by the anaerobes 
in the mixed biofilms that the E.coli inhabit, rather than evenly mixed throughout the 
intestine.  Furthermore, if one strain can bind better to the anaerobes in the mixed 
biofilms, the colonization ability of this strain would be improved.  Recent studies of 
bacterial biofilms in the intestines have shown that anaerobes form dense biofilms 
with E.coli as a minority member (22).  These biofilms form around intestinal mucin 
and break down large polysaccharides, such as fiber, that cannot usually be utilized by 
facultative anaerobes (22, 33, 40).  Differences in the population of anaerobes within 
mixed biofilms would thus provide E. coli with various niches based on nutrients 
made available by the anaerobes preferred metabolic pathways. 
While the anaerobes in mixed biofilms provide a source of nutrients for 
minimal members such as E. coli through breakdown of large polysaccharides, the 
facultative anaerobes may improve the environment for strict anaerobes by reducing 
the concentration of oxygen within the biofilms.  Oxygen diffuses from surrounding 
tissue into the intestines, oxygen from swallowed air is present in flatus, and at least 
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one predominant anaerobe in the gut microbiome, Bacteroides fragilis, respires 
oxygen at low concentrations (6, 16, 18, 23).  It has been shown that respiration in E. 
coli provides an important competitive edge when colonizing the intestine of 
streptomycin-treated mice.  Mutants of ATP synthase or cytochrome bd oxidase, both 
necessary for respiration, showed a significant loss in colonizing ability when 
colonized against wild type of the same strain (18). Since E. coli uses oxygen as the 
final electron-acceptor in respiration, the oxygen concentration within the intestine 
will be lower in the presence of E. coli. 
Conclusions 
While E. coli is only a minimal member of a large and dense microbial 
community found within the gut, it is still able to colonize and compete with such 
diversity even when co-colonized with other strains of E. coli.  It is likely that the 
relationships formed by colonizing E. coli strains within dense anaerobe-formed 
biofilms help develop unique niches not only for the E. coli, but also for the anaerobes 
that are in direct interaction with them.  Understanding how such a minor member is 
able to overcome such complexity, as well as the effects on the community it causes, 
is key to identifying mechanisms utilized by commensal and pathogenic bacteria to 
invade and colonize new hosts.  As such, this thesis aims to identify the effects of 
colonization by various strains of E. coli and the effects they have on the overall 
intestinal microbiota.  Furthermore, the development of a novel in vitro system used to 
aid in further understanding these relationships is discussed. 
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MANUSCRIPT I 
Analysis of how Different Strains of Escherichia coli Affect Development of the 
Intestinal Microbiota 
Abstract 
We previously proposed that colonizing strains of E. coli likely occupy specific 
niches as minimal members of mixed biofilms formed primarily by anaerobic 
members of the gut flora.  These “restaurants” formed by the different community 
members of the gut provide individual strains of E. coli with various unique binding 
pockets and locally provide mono- and disaccharides.  This allows strains of E. coli 
that cannot grow as efficiently on available sugars to colonize if they are able to 
occupy niches that other competing strains could not.  For example, if the less efficient 
strain could bind better to specific anaerobic members or had a higher tolerance for 
bile salts it would be able to co-colonize with a strain that could grow better on 
available sugars as it would not be in direct competition to occupy the same niche.   
As such, this study looks at how colonization with specific strains of E. coli can affect 
the development of the intestinal microbiota.  Five representative E. coli strains were 
used for this study: Nissle 1917, EDL933, MG1655, and two MG1655 mutants 
selected by the mouse gut (envZP41L and flhDC).  While slight variances were observed 
between strains, these were likely due to differences between hosts rather than the 
colonizing E. coli and no significant differences between the communities could be 
surmised. 
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Introduction 
The human intestinal tract is known to maintain a diverse population of 
microorganisms represented by both anaerobic and facultative anaerobic species (11, 
12).  It is well known that commensal strains of E. coli colonize as a minority member 
of these communities as a facultative anaerobe (27).  Commensal strains include 
organisms that naturally inhabit a host organism’s body without causing harm, and in 
some cases even providing the host with a particular advantage (25).  In contrast, a 
pathogenic strain is usually an invasive organism that may be of the same species, 
such as E. coli EDL933, but disease is caused rather than a harmless coexistence (25). 
To prevent infection by pathogens, probiotic strains that block or reduce the 
colonizing ability of pathogenic strains can be used, such as E. coli Nissle 1917 (25).  
Once colonized, a probiotic strain will fill the niche normally used by the pathogenic 
strain, preventing the pathogen from settling in.  According to Freter’s nutrient-niche 
hypothesis, colonizing strains can coexist as long as they are able to outcompete one 
another on one or more sugars, or are able to bind to the intestinal wall.  Thus if two 
strains (X and Y) are in direct competition and (X) can utilize all sugars better than 
(Y), then the less efficient strain (Y) cannot co-colonize (15).  This hypothesis 
assumes that all available nutrients are homogenized, or equally mixed, throughout the 
intestine (15). 
In order to compare the colonization ability of strains, mice are often used as a 
model system.  In order to test E.coli strains within animal models, the niches that are 
already filled by normal flora must be cleared.  If this is not done, any attempts at 
colonization will fail, as the niches are filled by other facultative anaerobes (8).  There 
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are currently two accepted models for testing the colonization ability of commensal 
strains in mice; the germ-free mouse model and the streptomycin treated mouse model 
(9, 24).  In germ-free mice, no microbiota are present.  This allows colonization to 
occur, but removes any relationships with anaerobes normally present as part of the 
microbiome (19).  The streptomycin-treated mouse model does leave much of the 
population intact, while still clearing the facultative anaerobe population for 
colonization to occur.  In this way the streptomycin-treated mouse model is superior, 
as relationships between anaerobes and the facultative anaerobes being tested are kept 
mostly intact (19). 
E. coli strain MG1655 is a common laboratory strain used to test colonization 
ability.  When colonized by said strain, the intestine selects for mutants with improved 
colonization ability.  These include a non-motile strain with a deletion in the flhDC 
region, and a motile strain with a missense mutation in the envZ gene (16, 26, 27).  
The flhDC operon is responsible for making the FlhD4C2 complex, which activates 
transcription of class II flagellar genes and represses a number of metabolic genes, 
including those involving sugar catabolism (14, 43, 44).  The deletion in the flhDC 
region removes the ability to produce this regulatory complex and has been shown to 
improve growth when compared to the parent MG1655 in vitro on cecal mucus and 
other available carbon sources normally found within the intestine (16, 26).  The envZ 
gene codes for the transmembrane osmolarity sensor protein EnvZ, a histidine kinase 
that acts on the OmpR regulatory protein as both a kinase and a phosphatase.  OmpR-
phosphate regulates a number of genes including: ompC, ompF, the sRNAs omrA and 
omrB, and flhDC (13).  The envZ missense mutant selected by the intestine, a P41L 
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mutant (ccg to tcg), reduces the phosphatase activity of EnvZ which results in a higher 
concentration of OmpR-phosphate (27).  In vitro the envZ missense mutation, 
hereafter called envZ P41L, results in a faster growth rate on several sugars relative to 
the parent MG1655 strain, and a slower growth rate relative to the flhDC deletion 
mutant on almost all sugars.  However, when grown in vitro on galactose, the envZP41L 
strain is far superior to both the parent MG1655 and flhDC deletion strains (27). 
The MG1655 envZP41L missense mutant strain was recently shown to have 
improved colonization ability against the parent MG1655 strain and colonized as well 
as the MG1655 flhDC deletion mutant (27).  In accordance with Freter’s hypothesis, 
the envZP41L and flhDC mutants should be able to co-colonize as both are able to grow 
well on different sugars and as such are not in direct competition.  As expected, when 
both strains are simultaneously fed to mice in the same nubers  (ie. 105 CFU per 
mouse) these mutant strains grow up to 109 CFU/gram of feces and co-colonize 
equally well thereafter.  Also, when 1010 CFU of the flhDC mutant is fed to mice 
along with 105 CFU of the envZP41L mutant, the envZP41L mutant is able to grow up in 
the intestine and almost reach the level of the flhDC mutant (21).  This again agrees 
with Freter’s hypothesis, as the strains are not in direct competition for sugars.  
However, when the 105 CFU of the flhDC mutant is fed to mice along with 1010 CFU 
of envZ P41L mutant, the flhDC mutant is unable to grow up against the envZ P41L 
mutant (27).  From these results, it can be inferred that there are at least two niches 
filled by envZ P41L mutant with some selective force that prevents flhDC from 
colonizing one of these niches, and that envZ P41L mutant is somehow able to prevent 
flhDC from growing up in the shared niche. 
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Our laboratory previously proposed an adjustment to the Freter’s hypothesis 
which states that the mono- and disaccharides that E. coli strains use for growth in the 
intestine are made available locally from polysaccharide degradation by the anaerobes 
in the mixed biofilms that the E.coli inhabit, rather than evenly mixed throughout the 
intestine.  Furthermore, if one strain can bind better to the anaerobes in the mixed 
biofilms, the colonization ability of this strain would be improved.  Recent studies of 
bacterial biofilms in the intestines have shown that anaerobes form dense biofilms 
with E.coli as a minority member (27).  These biofilms form around intestinal mucin 
and break down large polysaccharides, such as fiber, that cannot usually be utilized by 
facultative anaerobes (27, 40, 53).  Differences in the population of anaerobes within 
mixed biofilms would thus provide E. coli with various niches based on nutrients 
made available by the anaerobes preferred metabolic pathways.  If a specific mixed 
biofilm produced mostly galactose as a metabolic byproduct of polysaccharide 
breakdown, then envZ P41L mutant would be provided with a significant competitive 
edge over the flhDC deletion mutant in that biofilm. 
Due to the increased levels of OmpR-phosphate in the MG1655 envZ P41L mutant, 
the surface of the cells is different from both the parent MG1655 and the MG1655 
flhDC mutants.  OmpR-phosphate acts to upregulate two small RNAs (sRNAs), omrA 
and omrB.  These sRNAs are responsible for regulating outer membrane proteins by 
binding to the mRNA and preventing translation.  One of the targets of these sRNAs is 
cirA, which produces a surface protein that binds colicin toxins produced by other 
bacteria (5).  The MG1655 envZ P41L mutant has shown increased resistance to colicin 
V, a toxin produced by E. coli strain F-18, which could be representative of its 
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resistance to other bacteriocins produced in certain mixed biofilms throughout the 
intestine (27).  OmpR-phosphate also directly down regulates the production of the 
OmpF porin protein, which is known to transport bile salts into the cell.  With this 
reduction in OmpF, less bile salts can move into the cell, and MG1655 envZ P41L gains 
increased resistance to bile salts (27).  The flagella of MG1655 envZ P41L also remain 
intact allowing the cells to remain motile and adding yet another difference in the 
surface proteins of the MG1655 envZ P41L mutant vs. the MG1655 flhDC mutant.  
These differences in outer surfaces could provide the MG1655 envZ P41L mutant with 
an improved affinity towards members of the mixed biofilm niche where it is in direct 
competition with the MG1655 flhDC mutant.  With better binding affinity the 
MG1655 envZ P41L would have a lower washout rate than wildtype MG1655, allowing 
it to compete equally with the faster growth rate of the MG1655 flhDC mutant on most 
sugars.  The improved resistance of MG1655 envZ P41L to certain toxic substances in 
addition to improved binding affinity could increase the types of mixed biofilms with 
which it could associate. 
While the anaerobes in mixed biofilms provide a source of nutrients for minimal 
members such as E. coli through breakdown of large polysaccharides, the facultative 
anaerobes may improve the environment for strict anaerobes by reducing the 
concentration of oxygen within the biofilms.  Oxygen diffuses from surrounding tissue 
into the intestines, oxygen from swallowed air is present in flatus, and at least one 
predominant anaerobe in the gut microbiome, Bacteroides fragilis, respires oxygen at 
low concentrations (2, 18, 21, 28).  It has been shown that respiration in E. coli 
provides an important competitive edge when colonizing the intestine of streptomycin-
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treated mice.  Mutants of ATP synthase or cytochrome bd oxidase, both necessary for 
respiration, showed a significant loss in colonizing ability when colonized against wild 
type of the same strain (21). Since E. coli uses oxygen as the final electron-acceptor in 
respiration, the oxygen concentration within the intestine will be lower in the presence 
of E. coli.   Growth of anaerobes in close association with E. coli will be provided 
with a more preferential environment through depletion of oxygen, which is toxic to 
anaerobes.  This will allow the anaerobes to provide a better niche for the E. coli 
through increased breakdown of large polysaccharides, leading to a mutualistic 
relationship in which both the anaerobes and E. coli in mixed biofilms benefit. 
This study tested the hypothesis that the overall community structure of the gut 
may be influenced, and altered, by colonization with varying strains of E. coli.  Based 
on the differing surface structures, binding affinities, and sugar preferences of the E. 
coli strains discussed thus far, each strain might prefer a different “restaurant,” which 
would then lead to the preferential growth of the anaerobe members of the specific 
niche filled by each E. coli. 
Materials and Methods 
Bacterial strains: 
Bacterial strains used in this study are listed in Table 1. The original E. coli K-12 
strain was obtained from a stool sample from a convalescing diphtheria patient in Palo 
Alto, CA, in 1922 (1).  The sequenced E. coli MG1655 strain (CGSC 7740) was 
derived from the original K-12 strain, having only been cured of the temperate 
bacteriophage lambda and the F plasmid by means of UV light and acridine orange 
treatment (3).  It has an IS1 element in the flhDC promoter (14).  E. coli Nissle 1917 
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was originally isolated during World War I from a soldier who escaped a severe 
outbreak of diarrhea (50).  It has a beneficial effect on several types of intestinal 
disorders, is well tolerated by humans, and has been marketed as a probiotic remedy 
against intestinal disorders in several European countries since the 1920s (50).  The 
allelic exchange method described by Datsenko and Wanner (10) was used to 
construct E. coli MG1655 StrR Δ flhDC::cam (Table 1), 546-bp deletion 
encompassing region immediately downstream of ISI in regulatory region of flhD and 
into flhD.  E. coli EDL933 is the prototype strain of enterohemorrhagic E. coli 
(EHEC) O157:H7 (42). 
Media and growth conditions: 
LB broth-Lennox (DIFCO) was prepared as directed (20g/L in water) and 
sterilized.  The approximate formula of LB broth Lennox (DIFCO) is listed as follows: 
10g/L tryptone, 5g/L yeast extract, 5g/L sodium chloride.  Bottles containing 10 ml of 
LB broth Lennox (DIFCO) were inoculated with an individual strain of E. coli (Table 
1) and allowed to grow for 18 h while shaking at 200rpm at 37oC.  The overnight 
cultures grew to approximately 109 CFU/ml, which were then diluted into 20% (w/v) 
sucrose to 105 CFU/ml. 
Colonization experiments: 
The specifics of the streptomycin-treated mouse model used to compare the large 
intestine colonizing abilities of E. coli strains in mice have been described previously 
(34, 38, 54, 55, 56). Briefly, sets of three male CD-1 mice (5 to 8 weeks old) were 
given drinking water containing streptomycin sulfate (5 g/L) for 24 h to eliminate 
resident facultative bacteria (35). Following 18 h of starvation for food and water, the 
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mice were fed 1 ml of 20% (w/v) sucrose containing 105 CFU of LB broth Lennox 
(DIFCO) grown E. coli strains. After ingesting the bacterial suspension, both the food 
(Teklad mouse and rat diet; Harlan Laboratories, Madison, WI) and streptomycin-
water were returned to the mice, and 1 g of feces was collected after 5 h, 24 h, and on 
odd-numbered days at the indicated times. Mice were housed individually in cages 
without bedding and were placed in clean cages at 24 h intervals. Individual fecal 
pellets were therefore no older than 24 h. Each fecal sample (1 gram) was 
homogenized in 10 ml of 1% Bacto-Tryptone (DIFCO), diluted in the same medium, 
and plated on Lactose MacConkey agar plates (DIFCO) with appropriate antibiotics. 
When appropriate, 1 ml of a fecal homogenate (which were sampled after the feces 
have settled) were centrifuged at 12,000 x g, resuspended in 100 µl of 1% Bacto-
Tryptone, and plated on a Latose MacConkey agar plate with appropriate antibiotics. 
This procedure increases the sensitivity of the assay from 102 CFU/gram of feces to 10 
CFU/gram of feces.  To distinguish the various E. coli strains in feces, dilutions were 
plated on lactose MacConkey agar containing streptomycin sulfate (100 µg/ml), 
streptomycin sulfate (100 µg/ml) and nalidixic acid (50 µg/ml), streptomycin sulfate 
(100 µg/ml) and rifampicin (50 µg/ml), or streptomycin sulfate (100 µg/ml) and 
chloramphenicol (30 µg/ml). Streptomycin sulfate, chloramphenicol, rifampicin, and 
nalidixic acid were purchased from Sigma-Aldrich (St. Louis, MO). All plates were 
incubated for 18 to 24 h at 37°C prior to counting (27).  Mice were colonized with a 
single representative strain of E. coli for 10 days prior to harvesting of cecum.  The E. 
coli strains used were (see Table 1): an O157:H7 pathogenic strain (EDL933), the 
probiotic strain (Nissle 1917), a common laboratory strain (MG1655), and the two 
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mutants of MG1655 selected by the mouse intestine (envZ P41L and flhDC). Also 
included were a set of mice inoculated with a placebo of uninoculated 20% sucrose. 
Fluorescent in situ Hybridization (FISH): 
In order to study how different strains of E. coli associate locally with members 
of the microbiota, we used Fluorescent In Situ Hybridization (FISH) on cross-sections 
of cecum from streptomycin-treated mice colonized with a single strain of E. coli.  
This was done in parallel with community analysis sequencing of bacterial populations 
in mucus samples obtained from the cecum of similarly treated mice to better 
understand how each strain of E. coli affects the development of the microbiome as a 
whole.  The mice included an uninoculated control set (blank 20% sucrose) and mice 
inoculated with one of five representative strains of E. coli listed above. Each strain, as 
well as the control, was fed simultaneously to 6 mice (105 CFU/mouse), which were 
colonized for 10 days.  On the tenth day, mice were killed via CO2 and their ceca were 
harvested.  Three of the mice from each set were used for FISH, while 3 of the mice 
from each set were used for community analysis sequencing of mucus samples. 
The cecum of a mouse designated for FISH was cut into 1-2 cm sections, 
suspended in TissueTek® O.C.T compound (Sakura Finetek USA, Inc.) and snap 
frozen in 2-methylbutane suspended in liquid nitrogen.  Sections were then stored at -
80oC until ready for sectioning.  For sectioning, the Vibratome UltraPro 5000 cryostat 
was used to cut sections at a thickness of 10um, which were adhered to poly-L-lysine 
treated slides for visualization (LabScientific, Inc).  Fixing of slides was done in 4% 
Paraformaldehyde for 1 hour at room temperature, followed by a wash in PBS for 10 
min.  Slides were allowed to dry overnight prior to hybridization.  Fluorescent probes 
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were diluted in hybridization solution consisting of 10 ml of 1M Tris pH7.2, 18 ml of 
5M NaCl, and 0.1 g of SDS in a total volume of 100 ml H20.  All slides with sections 
were treated using the FISH technique used by S. Macfarlane et al. (31), with 
hybridization of E.coli specific (5’-/5Cy3/CACCGTAGTGCCTCGTCATCA-3’) Cy-3 
probe (red) and Eubacteria specific (5’-GCTGCCTCCCGTAGGAGT/36-FAM/-3’) 
FitC probe (green) at concentrations of 5ng/µl and 25ng/µl, respectively.  These 
probes were obtained from Integrated DNA Technologies (Coralville, IA).  Briefly, 
10µl of diluted probes in hybridization solution was pipetted to each slide, which were 
then covered with a HybriSlip hybridization cover (Life Technologies, Carlsbad, CA) 
and allowed to incubate in the dark for 2 h at 50°C.  After 2 h the slides were dipped 
in a wash buffer, which is simply hybridization solution without SDS added, and then 
allowed to soak in the wash buffer for 20 min at 50°C.  Slides were then rinsed with 
distilled water and allowed to dry overnight before viewing.  Sections on poly-L-
lysine treated slides were imaged using the Zeiss axioimager M2 imaging system with 
the Zeiss LSM 700 confocal microscope and corresponding lasers (Carl Zeiss, 
Oberkochen, Germany).  The images acquired from the poly-L-lysine treated slides 
were used to observe the biofilms with which the individual E. coli strains associate.  
The poly-L-lysine treated slides were additionally treated with Vectashield (Vector 
Laboratories, Inc.), an antibleaching agent which helps prolong fluorescence for 
imaging.  This involves placing a small drop of Vectashield on the hybridized slide 
and then covering with a coverslip.  Allowing 30 min at room temperature for the 
Vectashield to dry made viewing easier, but was not absolutely necessary. 
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Isolation of cecal mucus and DNA in cecal mucus: 
For each mouse cecum being used in sampling of microbiota in the mucus, mucus 
samples were scraped and collected into 5 ml of HEPES-Hanks buffer (pH7.2).  
Microbial DNA was isolated using a MO BIO PowerSoilTM DNA Isolation Kit. 
Sequencing: 
PCRs to prepare samples for sequencing were done similarly for all mucus 
scrapings.  Primers were designed to match those used in a study of the human gut 
microbiome which targeted the V4 variable region of the 16S rRNA (57).  These 
primers were obtained from Integrated DNA Technologies (Coralville, IA) and were 
as follows: Forward (5’-TCG TCG GCA GCG TCA GAT GTG TAT AAG A-3’) and 
Reverse (5’-GTC TCG TGG GCT CGG AGA TGT GTA TAA G-3’).  Taq DNA 
polymerase (New England BioLabs, Ipswich, MA.) was added to each PCR reaction, 
which consisted of 25µl reactions: 2.5µl 10x Standard taq Reaction Buffer (New 
England BioLabs Inc.), 0.5µl dNTP Solution Mix containing 10 mM of each dNTP 
(New England BioLabs Inc.), 0.5µl of a 100µM solution of each primer, 0.5µl of the 
aforementioned taq DNA polymerase (New England BioLabs), all added to 17.5µl of 
DEPC treated nuclease free sterile water (Fisher Scientific).  Each PCR reaction began 
with an initial denaturation of 95°C for four min followed by a cycle of three steps 
repeated 35 times.  These were as follows: denature at 95°C for 30 s, annealing at 
55°C for 20 s, and extension at 72°C for 30 s.  The PCR ended with a final primer 
extension at 72°C for 4 min.  PCR was done using an Eppendorf® Mastercycler 5331 
Gradient PCR Thermocycler (Westbury, NY).  PCR products were checked via gel 
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electrophoresis to be sure they contained one band of approximately 300 bp before 
submission to the Rhode Island Genomics and Sequencing Center (RIGSC). 
Once submitted to the RIGSC, after amplicon submission, a second round of PCR 
(5 cycles) to attach Nextera (Illumina) indices and adapters was performed.  Round 2 
PCR reactions were cleaned with Agencourt Ampure XP (Beckman Coulter, Inc.), 
visualized by agarose gel electrophoresis, and selected samples were analyzed using 
the Agilent BioAnalyzer DNA1000 chip (Illumina). Qubit quantification was 
performed on all samples prior to pooling, and KAPA quantification was performed 
on the final pooled library prior to loading on the MiSeq flow cell.  The samples were 
then run on the Illumina MiSeq (Illumina RTA 1.17.28) hi-throughput sequencer. 
Sequencing analysis: 
Data output from the MiSeq comes as raw fastq files, which were then classified 
using the published Mothur pipeline version 1.33 (49).  Sequence processing was 
aligned, cleaned of chimeric sequences, and classified using the MiSeq SOP (standard 
operating procedure) made available by the Mothur authors (49). 
Statistics   
Means and standard deviations derived from the indicated samples were 
compared by an unpaired Student's t test (P values).  A P value of >0.05 was 
interpreted as indicating no significant difference, and a P value of <0.05 was 
interpreted as indicating a significant difference. 
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Results 
Comparing communities 
The quantification of the level of colonization by each strain was measured by 
diluting and plating feces collected from colonized mice, as previously described (Fig. 
1).  Each E. coli strain was able to colonize mice at between 108 and 109 CFU/g feces.  
As the control mice were fed a 20% sucrose placebo (without the addition of any E. 
coli) strain, no E. coli colonies should have grown when plated on MacConkey agar 
without any antibiotics added.  As expected, no colonies were seen.  FISH images 
confirm that the strains exist in close proximity to other members of the gut 
microbiota as a minimal member in larger biofilms (Fig 2-7).  It can also be seen in 
these images that the non-E. coli microbes are diverse in cell morphology. 
Once the interaction between the E. coli strains and the members of the 
microbiota had been confirmed, as well as the diversity of the microbial community, 
the community structure of each individual strain was compared.  This was done at the 
phylum and family levels.  As seen in (Fig. 8), all colonized mice showed similar 
levels of Bacteroidetes, and Firmicutes.  For the E.coli Nissle 1917 and E. coli 
EDL933 colonized mice, Deferribacteres seemed to be at lower levels than for mice 
colonized with the other E. coli.  Upon comparing the Nissle 1917 and EDL933 
colonized mice to mice colonized with all of the other E. coli strains through an 
unpaired students t test, it was shown that these low levels are only statistically 
relevant when compared to the control and conventional mice (P < 0.0001).  Mice that 
were not colonized with any of the tested E. coli strains, i.e. the streptomycin treated 
controls and untreated conventional mice, showed very little Proteobacteria at this 
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level of classification.  In contrast, the E. coli colonized mice showed much higher 
levels of Proteobacteria, with the exception of the MG1655 envZ P41L and flhDC 
mutants.  The envZ P41L and flhDC mice showed lower levels of Proteobacteria when 
compared to the other treatments inoculated by E. coli strains, but only the envZ P41L 
was statistically different in terms of Proteobacteria and only when compared to Nissle 
1917 (P < 0.05).  Even the Proteobacteria in the conventional and control mice were 
only statistically different from Nissle 1917 (P < 0.05). 
It appears that mice colonized with all the E. coli strains display similar diversity 
at the family level (Fig. 9), with high levels of many of the same major members 
across all mice.  Statistically relevant differences between the population of s24-7, a 
member of the Firmicutes phylum found in mice, is lower in Nissle 1917 samples 
when compared to MG1655 envZP41L samples (P < 0.02), streptomycin treated 
controls (P < 0.01), and the MG1655 flhDC mutant samples (P < 0.002).  
Deferribacteraceae is considerably lower in Nissle 1917 and EDL933 colonized mice 
when compared to control (P < 0.0001) and conventional mice (P < 0.0001).  EDL933 
colonized mice had the lowest level of Lachnospiraceae, which was only a statistically 
significant difference when compared to MG1655 envZ P41L colonized mice  (P < 
0.05).  Mice colonized with the MG1655 envZP41L and MG1655 flhDC mutants had 
lower levels of Enterobacteriaceae when compared to the mice colonized with the 
other E. coli strains, but only Nissle 1917 colonized mice were statistically higher and 
only when compared to mice colonized with the MG1655 envZP41L mutant (P < 0.05).  
The same was true for the control and conventional mice, with only Nissle 1917 
colonized mice being statistically different in levels of Enterobacteriaceae (P < 0.05). 
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Increasing the sample set for Nissle 1917 and MG1655 
From the initial MiSeq sample set it was concluded that no significant difference 
could be observed in the cecal mucus community structures of mice colonized with the 
5 different E. coli strains.  While certain differences did appear (i.e. s24-7 in Nissle 
1917) this may have been due to the limited sample set (n=3), and so a second MiSeq 
run was performed.  Rather than testing only a few additional mice for each strain, 2 
strains were chosen so as a larger data set could be gathered for each: Nissle 1917 and 
MG1655.  These strains were chosen as they are known to have different preferences 
in terms of growth on sugars, and are able to co-colonize the gut without being in 
direct competition (28). 
An additional 11 mice colonized with MG1655 and 12 mice with Nissle 1917 
were used.  This would clarify if a larger sample size would allow visualization of 
changes in the overall microbial community caused by colonization with specific 
strains of E. coli.  The relative abundance of major members of the gut microbiota was 
compared at the phylum and family level in order to ascertain if colonization by 
individual E. coli strains resulted in a percentage shifts of the major members, or if 
different major members appeared. 
As is seen in the (Fig. 10), Nissle 1917 colonized mice have a higher relative 
abundance of Proteobacteria when compared to MG1655 (P < 0.02), and both Nissle 
1917 and MG1655 fed mice have more Proteobacteria than the streptomycin treated 
control mice (P < 0.0001 and P < 0.02, respectively).  This difference is seen again at 
the family level (Fig. 11) as represented by Enterobacteriaceae (a family in the 
Proteobacteria phylum) with Nissle 1917 colonized mice having more 
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Enterobacteriaceae than MG1655 colonized mice (P < 0.02), and both Nissle 1917 and 
MG1655 colonized mice having more Enterobacteriaceae than the streptomycin 
treated control mice (P < 0.0001 and P < 0.02, respectively).  As the mice were treated 
with streptomycin in order to clear natural Proteobacteria from the niches that 
colonizing strains would inhabit, this difference in levels when compared to the 
streptomycin treated controls would be expected.  As for the other members of the 
microbiota, there were no statistically significant differences between the individual E. 
coli treatments. 
Discussion 
In the present study, we examined the community structure of mice colonized 
with various strains of E. coli and their individual effects on the diversity of the cecal 
mucus population.  It has been shown that E. coli inhabits the gut as a minimal 
member of mixed biofilms consisting of large anaerobe populations (27, Fig. 2-7), and 
while certain major members of the population may be influenced by colonization 
with specific strains of E. coli, more samples are likely necessary in order to elucidate 
any statistically relevant shift in a population.  This is shown in comparing the Nissle 
1917 data, which in the first sample set (n=3) showed changes in levels of s24-7 and 
Deferribacteriaceae, but increasing the sample size (n=15) debunks this finding as 
Deferribacteriaceae and s24-7 are present at a higher relative abundance (Fig. 9 vs Fig. 
11).  It is important to note however that the depth of sequencing is important for 
identifying key differences in these experiments, as the family level shows much 
greater differences than the phylum level.  Future work would likely need to focus on 
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the family level, or if able to, the genus level of classification to elucidate key 
differences caused by the colonizing E. coli strains. 
Deferribacteres is a relatively recently described lineage, but one genus of 
Deferribacteres, Mucispirillum, has been identified as existing in the mammalian gut 
and being able to degrade mucin (20, 48).  Lachnospiraceae is a member of the 
Firmicutes that is able to produce butyric acid and has been previously linked to 
obesity (36).  Ruminococcaceae, another Firmicutes, has been previously shown to 
exist in the gut, but is difficult to classify and is often a mistakenly identified 
Lachnospiraceae (30).  Paenibacillaceae is a Firmicutes with species that exist as plant 
growth promoting rhizobacteria and may have been introduced through the feed given 
to mice (4).  The s24-7 family is a member of the Bacteroidetes that has been found to 
inhabit the mouse gut, but little else has been described (17).  Another bacteroidetes, 
Porphyromonadaceae, has been previously shown to occasionally inhabit the gut, but 
more often resides in oral cavities as a pathogen (39).  Rikanellaceae is another 
Bacteroidetes that has a recently reclassified member, Alistepes putredinis which was 
previously classified as a Bacteroides and shows similarities with Bacteroides fragilis 
and members of Porphyromonadaceae (47).  Bacteroidaceae contains the Bacteroides 
genus, which can use simple sugars when available, but use glycans as a main source 
of energy (33). 
Variation in the microbial communities amongst different hosts is common, and 
even hosts from a common facility or litter may have differences amongst the 
populations that inhabit their guts (29, 37, 45).  This is illustrated by the fact that mice 
used to test the same E. coli strain, and at the same time and under identical 
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conditions, show differences in their community structures.  As seen in (Fig. 9), 
showing the relative abundance at the family level of an individual E. coli strain, the 
standard deviation is considerable for many of the organisms present.  Some families 
aren’t even present in some of the mice, but are in high enough number to be 
represented in another mouse.  As such, it is possible that any small effect in 
colonization by an individual E. coli strain could be masked by this diversity amongst 
hosts. 
In addition to variation amongst hosts, the microbiota also consists of a vast 
amount of members (between 500-1000 commensal strains [6, 7, 22, 41, 46, 51, 52]).  
This could further mask any alteration in the community structure induced by 
colonization with specific E. coli strains.  If a specific organism were present as a 
major member of the microbiota in one mouse, but only a minor member (or not 
present at all) in another mouse, this would result in a large standard deviation for that 
organism.  So, even if a colonizing E. coli had an effect on this specific organism in 
the population, it would look the same as if it were just an artifact of having different 
hosts.  This is further complicated by the overall noise level of the gut, again 
comprising of 500-1000 different organisms. 
While the diversity between mice, as well as the large and complicated 
community of the gut, may mask shifts in the populations caused by colonizing E. coli 
it is still likely that the overall composition of the gut is not affected by the 
colonization of a specific E. coli strain.  However, this does not mean E. coli is not 
important within the community and could still have a more localized effect on 
members of the population.  Direct cell to cell interactions between E. coli and 
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members of the microbiota that are within close proximity of one another may be 
more directly affected by these individual strains, as opposed to an obvious shift in 
large populations within the microbiome.  Redundancy of gene programs and 
processes may allow the overall population to remain mostly unaffected by a minimal 
member missing from the population (19), but a more subtle effect may occur in 
localized niches.  Further studies of direct cell to cell interactions may be necessary to 
elucidate how an individual E. coli strain can affect the communities of the 
mammalian gut, such as laser capture micro-dissections (LCM) (23).  LCM coupled 
with FISH techniques would allow the targeting of fluorescently labeled E. coli cells 
within mixed biofilms to be captured and used for community analysis sequencing.  
This would allow only the members in close association with the E. coli to be studied, 
and remove much of the noise created by the overall communities of the gut. 
In summary, the data presented here suggest that colonization with different 
strains of E. coli does not affect the overall composition of the microbial communities 
found within mouse cecal mucus.  While increasing the sample size may give clarity 
to some minute effects that occur due to colonization with these individual strains, it is 
likely the overall noise level of the gut and the variation in the communities between 
hosts will mask these effects.  Moving forward, it could prove useful to directly study 
the members that closely associate with the colonizing E. coli strains, through use of 
laser capture micro-dissections, in order to avoid the clutter of the dense microbial 
communities.  Furthermore, focusing on deeper levels of classification could help 
elucidate differences in these populations. 
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Table 1 – Bacterial strains 
E. coli strain Genotype/phenotype Designation in 
the text 
Source or 
reference 
MG1655 StrR Spontaneous streptomycin 
resistant mutant of MG1655 
MG1655 3 
MG1655 
StrR ΔflhD::cam 
 
546-bp deletion beginning 
immediately downstream of 
IS1 in the regulatory region of 
flhD and ending in flhD, 
streptomycin and 
chloramphenicol resistant 
MG1655 
flhDC 
15, 23 
MG1655 envZ 
P41L StrR 
P41L envZ missense mutant of 
MG1655 StrR 
MG1655 
envZP41L 
mutant 
24 
Nissle 1917 StrR Spontaneous streptomycin 
resistant mutant of Nissle 1917 
Nissle 1917 22, 41 
EDL933 StrR RifR Spontaneous streptomycin 
resistant mutant of EDL933 
EDL933 35 
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Table 2 – Primers used 
Primer designation Sequence 
of E.coli specific Cy-3 probe 
(red) used for FISH 
5’-/5Cy3/CACCGTAGTGCCTCGTCATCA-3’ 
Eubacteria FitC probe (green) 
used for FISH 
5’-GCTGCCTCCCGTAGGAGT/36-FAM/-3’ 
16S V4 forward used for 
community analysis sequencing 
5’-TCG TCG GCA GCG TCA GAT GTG TAT 
AAG A-3’  
16S V4 reverse used for 
community analysis sequencing 
5’-GTC TCG TGG GCT CGG AGA TGT GTA 
TAA G-3’ 
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Fig 1. Single strain colonizations of mice colonized with individual strains of E. coli.  
This shows that the individual E. coli strains are able to colonize the mice at similar 
levels. 
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Fig 2. FISH image of a cross-section of cecum collected from mice colonized with 
EDL933 for 10 days.  Red bacterial cells represent E. coli labeled by the Cy3-probe, 
while green bacterial cells represent all Eubacteria labeled by the FitC-probe.   
 47 
 
 
Fig 3. FISH image of a cross-section of cecum collected from mice colonized with 
Nissle 1917 for 10 days.  Red bacterial cells represent E. coli labeled by the Cy3-
probe, while green bacterial cells represent all Eubacteria labeled by the FitC-probe.   
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Fig 4. FISH image of a cross-section of cecum collected from mice colonized with 
MG1655 for 10 days.  Red bacterial cells represent E. coli labeled by the Cy3-probe, 
while green bacterial cells represent all Eubacteria labeled by the FitC-probe.   
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Fig 5. FISH image of a cross-section of cecum collected from mice colonized with 
MG1655 flhDC for 10 days.  Red bacterial cells represent E. coli labeled by the Cy3-
probe, while green bacterial cells represent all Eubacteria labeled by the FitC-probe. 
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Fig. 6. FISH image of a cross-section of cecum collected from mice colonized with 
MG1655 envZP41L for 10 days.  Red bacterial cells represent E. coli labeled by the 
Cy3-probe, while green bacterial cells represent all Eubacteria labeled by the FitC-
probe.    
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Fig. 7 FISH image of a cross-section of cecum collected from mice treated with 
streptomycin but not colonized with any E. coli.   Green bacterial cells represent all 
Eubacteria labeled by the FitC-probe. 
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Fig. 8 Bar plot showing relative abundance of major phyla in mucus samples by 
treatment.  In this set of experiments n=3.  Error bars indicate standard error of the 
mean.  EDL933 and Nissle 1917 colonized mice show lower levels of Deferribacteres 
when compared to the control and conventional mice (P < 0.0001).  Only Nissle 1917 
shows greater levels of Proteobacteria, and only when compared to MG1655 envZP41L 
and the control and conventional mice (P < 0.05). 
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Fig. 9 Bar plot showing relative abundance of major families in mucus samples by 
treatment.  In this set of experiments n=3.  Error bars indicate standard error of the 
mean.  The level of s24-7 in the Nissle 1917 colonized mice was lower when 
compared to the MG1655 mutants (envZP41L P < 0.02 and flhDC P <0.002) and the 
streptomycin treated control (P < 0.01).  Deferribacteraceae was lower in Nissle 1917 
and EDL933 colonized mice when compared to the control and conventional mice 
(P < 0.0001).  EDL933 colonized mice had the lowest level of Lachnospiraceae, which 
was only a statistically significant difference when compared to MG1655 envZP41L 
colonized mice (P < 0.05).  Enterobacteriaceae were lower in the envZP41L, control and 
conventional mice when compared to Nissle 1917 mice (P < 0.05) 
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Fig. 10 Bar plot showing relative abundance of major phyla in mucus samples by 
treatment.  For Nissle1917 samples n=15.  For MG1655 samples n=14.  For 
streptomycin treated control samples n=15.  Error bars indicate standard error of the 
mean.  The ony statistically significant differences were seen in the levels of 
Proteobacteria, with Nissle 1917 fed mice having more than MG1655 fed mice (P < 
0.02), and both Nissle 1917 and MG1655 fed mice having more Proteobacteria than 
the streptomycin treated controls (P < 0.0001 and P < 0.02, respectively).
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Fig. 11 Bar plot showing relative abundance of major families in mucus samples by 
treatment.  For Nissle1917 samples n=15.  For MG1655 samples n=14.  For 
streptomycin treated control samples n=15.  Error bars indicate standard error of the 
mean.  Nissle 1917 colonized mice having more Enterobacteriaceae than MG1655 
colonized mice (P < 0.02), and both Nissle 1917 and MG1655 colonized mice having 
more Enterobacteriaceae than the streptomycin treated control mice (P < 0.0001 and 
P < 0.02, respectively) 
.
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MANUSCRIPT II 
Developing an In Vitro Method for Studying the Interaction between E. coli and the 
Intestinal Microbiota 
Abstract 
In order to better understand the interactions between E. coli and the members 
of the intestinal microbiota, a novel in vitro method was developed.  This method was 
designed to be simple and inexpensive while providing an environment meant to 
replicate the natural habitat of these organisms: the mammalian gut.  The current study 
examines the development of said in vitro model and its ability to mimic the mouse 
gut in terms of diversity of organisms, as well as its usefulness in examining the 
colonizing ability of competing E. coli strains.  It is shown that, while still in 
development, this system is currently able to maintain diversity comparable to what is 
seen in mice.  While the abundance of these diverse organisms is not necessarily at the 
levels seen in mice, the model is already an effective system for studying the microbial 
community of the gut in a controlled environment.  Furthermore, the system is able to 
mimic certain colonization experiments of competing E. coli strains done in mice, and 
with improvements to bolster the growth of the diverse population could be used as a 
non-invasive method for studying gut microbes. 
Introduction 
While there are a diverse group of phyla represented within the mammalian 
gut, the microbiota is dominated by two: Firmicutes and Bacteroidetes (15, 30, 55).  
Facultative anaerobes, such as E. coli, are minimal yet important members of the gut 
community, and it has been shown that E. coli inhabits mixed biofilms formed by 
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anaerobes as a minority member (28).  According to Freter’s nutrient-niche hypothesis 
the community structure of the intestine is decided by nutrient availability, but also 
assumes that all available nutrients within the intestine are perfectly mixed (17).  We 
previously proposed an adjustment to Freter’s nutrient-niche hypothesis, the 
“Restaurant” hypothesis, which can be used to explain how the anaerobes in mixed 
biofilms inhabited by E. coli provide them with mono- and di-saccharides locally, 
rather than from a perfectly mixed pool available to all species (28).  Furthermore, it 
was hypothesized that differences in the outer surface between strains of E. coli may 
have an effect on the binding affinity to the mixed biofilms and their consequent 
growth (28). 
Mucus in the gut exists in two forms, the loose layer and the firm layer (24).  
The loose mucus layer is where most of the microbiota of the gut grow and form their 
biofilms, while the firm mucus layer resides closer to the epithelial layer of the 
intestines and prevents direct interaction of the commensal microbiota with host 
epithelium (24).  The mucus itself consists of a large mixture of molecules, including 
but not limited to amino acids, large polysaccharides, mono- and disaccharides, and 
mucin (3).  This mixture exists as a viscous liquid in which the microbes are 
suspended and in which form biofilms.  This environment is mostly anaerobic, with 
minimal oxygen leaking from epithelial cells of the intestine (4, 20, 25, 29).  Mucin is 
a glycoprotein with large polysaccharide strands with which the anaerobe populations 
of the gut can attach and form biofilms around (1).  The biofilms formed by these 
anaerobes can break down the large polysaccharides of the mucus, and parts of the 
mucin, thus providing facultatives with usable mono- and disaccharides in bulk which 
 59 
 
would usually be limited (28, 43, 56).  This gives facultatives, such as E. coli, a reason 
for joining as minimal members in these anaerobe-formed biofilms, and perhaps even 
promoting the growth of preferential anaerobes that provide specific mono- and 
disaccharides (25).  The facultatives that join these mixed biofilms likely provide the 
anaerobes with protection from the minimal amount of oxygen that is released from 
the epithelial tissue of the gut. 
In vitro biofilm models allow the study of microbial communities as they form 
complex biofilm structures in a contained and controllable environment (14, 21, 61).  
Various biofilm models have been adapted to represent specific environments in order 
to best mimic biofilm formation in vivo.  These systems are diverse in setup and 
function, ranging from flow displacement systems in which a constant flow of growth 
medium in and waste products out (4, 21), to cell-culture-based models which allow 
biofilms to develop on reconstituted human epithelia (50). 
One system that is commonly used to study biofilms due to its simplicity is the 
microtiter plate based model (8, 26, 46, 59).  The biofilms using this model are grown 
in microtiter well plates ranging from 6 to 96 well plates depending on necessity.  This 
allows for many environmentally identical biofilms to be studied at once, or individual 
variables to be tested in each well (42).  This system also allows for easy adjustment 
over time in order to view the effects of variation in the media or additives on biofilm 
development or maintenance (9, 23).  However, a disadvantage of the microtiter plate 
based models is that the system does not take into account the flow through of certain 
environments such as the mouse gut (11, 47).  This would mean that biofilms growing 
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in the wells of the microtiter plate would eventually deplete available nutrients while 
also accumulating waste (11). 
Other systems take into account that the flow of new media into and old media 
out of the system is important.  These flow models vary in design, with some 
developed to maintain a perfect mixture of nutrients and other more simplistic systems 
which allow the flow of the media to develop a natural gradient from one end of the 
flow to the other (21).  The continuous flow stirred tank reactor (CFSTR), a system 
utilized by the CDC for biofilm studies, has an influx that matches the flow out of the 
system with constant stirring where the biofilms grow (21).  Planktonic cells can be 
flushed out of the system by having the dilution rate of the media set faster than the 
doubling time of the organisms in the system, leaving behind the attached organisms 
in biofilms (21).  The plug flow reactor (PFR) is similar in the control of media flow, 
but does not have a container of media with constant stirring.  Instead, plugs seeded 
with biofilm forming organisms are locked in a row and media is allowed to flush past 
them.  Thus the media will have a higher concentration of substrates earlier in the flow 
with a gradual decline in concentration further down the system (11, 21).  While these 
systems are designed to mimic the natural flow of available substrates in certain 
environmental habitats, they also come with disadvantages.  The continuous flow 
stirred tank reactor setup tends to be labor intensive, with specialized equipment that 
can be difficult to use or maintain.  Both flow systems suffer from only being able to 
test a single biofilm forming community per setup or experiment, as is a similar issue 
with the media flowing into the system.  The media required to maintain the system is 
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also a substantial amount, as the constant flow requires fresh media to be prepared 
based on the rate of flow (11). 
In order to avoid some of the disadvantages of the previously described 
systems, a simple in vitro system was developed with the specific intention of 
mimicking bacterial growth in the mammalian gut.  The developed gut system was 
designed to be simplistic in nature, making it accessible to other researchers interested 
in studying microbial communities in biofilms.  The flow through of the natural gut 
was also considered, and the system was developed with a dilution system meant to 
mimic the diminishing and regrowth of the populations due to the constant flow of 
mucus (47).  Additionally, due to the simple dilution of growth into fresh media, 
multiple variables could be tested on biofilms developed from a single source thus 
allowing the observation of multiple conditions on identical biofilm communities.  
The developed system is also small enough to be contained in a single microcentrifuge 
tube, which allows for multiple samples or experiments to be run in tandem. 
Materials and Methods 
Bacterial strains: 
Bacterial strains used in this study are listed in Table 1. The original E. coli K-
12 strain was obtained from a stool sample from a convalescing diphtheria patient in 
Palo Alto, CA, in 1922 (Bachman BJ, 1996).  The sequenced E. coli MG1655 strain 
(CGSC 7740) was derived from the original K-12 strain, having only been cured of the 
temperate bacteriophage lambda and the F plasmid by means of UV light and acridine 
orange treatment (7).  It has an IS1 element in the flhDC promoter (16).  E. coli Nissle 
1917 was originally isolated during World War I from a soldier who escaped a severe 
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outbreak of diarrhea (53).   It has a beneficial effect on several types of intestinal 
disorders, is well tolerated by humans, and has been marketed as a probiotic remedy 
against intestinal disorders in several European countries since the 1920s (53).  E. coli 
EDL933 is the prototype strain of enterohemorrhagic E. coli (EHEC) O157:H7 (45).  
The allelic exchange method described by Datsenko and Wanner (datsenko wanner 
2001) was used to construct E. coli EDL933 StrR ΔppsA ΔpckA::cam (Table 1), with 
deletions of 2,367 and 1,341 bp  in the ppsA gene and the pckA gene, respectively.  
Phosphoenolpyruvate carboxykinase converts oxaloacetate to phosphoenolpyruvate 
and is encoded by the E. coli pckA gene (35). Phosphoenolpyruvate synthase is 
encoded by the E. coli ppsA gene and converts pyruvate to phosphoenolpyruvate (41). 
Since the conversion of TCA cycle intermediates to phosphoenolpyruvate is 
completely blocked in a ppsA pckA double mutant, it is unable to grow on 
gluconeogenic substrates “below” the step of phosphoenolpyruvate, but glycolytic 
pathways are not affected (18). 
Media and growth conditions: 
LB broth-Lennox (DIFCO) was prepared as directed (20 g/L in water) and 
sterilized.  The approximate formula of LB broth Lennox (DIFCO) is listed as follows: 
10 g/L tryptone, 5 g/L yeast extract, 5 g/L sodium chloride.  Bottles containing 10 ml 
of LB broth Lennox (DIFCO) were inoculated with an individual strain of E. coli 
(Table 1) and allowed to grow for 18 h while shaking at 200 rpm at 37°C.  The 
overnight cultures grew to approximately 109 CFU/ml, which were then diluted to 105 
CFU/ml in 20% (w/v) sucrose when intended for mouse colonization, or HEPES-
Hanks buffer when diluted for addition into the in vitro system. 
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HEPES-Hanks buffer is 8 g/L NaCl, 0.4 g/L KCl, 0.185 g/L CaCl, 0.2 g/L MgSO4, 0.5 
g/L Na2HPO4, 0.35 g/L KH2PO4, and 2.6 g/L HEPES in distilled water.  This solution 
was brought to pH 7.2 through addition of NaOH and filter sterilized (12).  For the 
experiments in which agarose was added, agarose was prepared separately at 0.6% 
agarose (w/v) in distilled water and HEPES-Hanks buffer was prepared at twice the 
above listed concentrations.  The agarose was prepared fresh daily, and, as autoclaving 
the agarose expels oxygen, provided further removal of oxygen from the samples.  The 
agarose and HEPES-Hanks were then mixed 1:1. 
For the in vitro gut model, cecal mucus samples were harvested from the E. 
coli colonized streptomycin-treated mice into 1 ml of HEPES-Hanks buffer (pH7.2) 
including a reducing agent (3 mM Cleland’s reagent) to help prevent oxygen 
poisoning of the anaerobe population within the sample, as well as 500 ug/ml porcine 
intestinal mucin (Sigma).  This sample was mixed thoroughly via pipetting, and then 
incubated in a BD anaerobic GasPak™ system (Becton, Dickinson and Company) 
overnight at 37oC.  The following day, a 100µl sample of the overnight growth cecal 
mucus bacterial culture was used to inoculate a fresh 1 ml sample of HEPES-Hanks 
containing 2 mg/ml lyophilized mucus, 500µg/ml Porcine intestinal mucin (Sigma), 3 
mM Cleland’s reagent, and 0.3% agarose.  The freshly inoculated 1 ml sample was 
labeled as Day 0 and incubated in a BD anaerobic GasPak™ system (Becton, 
Dickinson and Company) overnight at 37°C. This procedure was repeated for 7 days, 
using 100µl to inoculate a new 1 ml sample of fresh HEPES-Hanks containing 2 
mg/ml lyophilized mucus, 500µg/ml Porcine intestinal mucin, 3 mM Cleland’s 
reagent, and 0.3% agarose. 
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When using the in vitro method to compare colonization ability, slight 
alterations were made to accommodate multiple strains.  Initial sampling remained the 
same, with pre-colonized mouse mucus being collected into 1 ml of HEPES-Hanks 
buffer (pH7.2) including a reducing agent (3 mM Cleland’s reagent) to help prevent 
oxygen poisoning of the anaerobe population within the sample, as well as 500µg/ml 
porcine intestinal mucin (Sigma).  This sample was mixed thoroughly via pipetting, 
and then incubated in a BD anaerobic GasPak™ system (Becton, Dickinson and 
Company) overnight at 37°C.  On the same day as collection, strains to be used for 
competitions were grown overnight in LB at 37°C while shaking.  The following day, 
a 10µl sample of the overnight culture was used to inoculate a fresh 1 ml sample of 
HEPES-Hanks buffer containing 2 mg/ml lyophilized mucus, 500µg/ml Porcine 
intestinal mucin (Sigma), 3mM Cleland’s reagent, and 0.3% agarose.  At this point, 
10µl of the strains to be used for competition were diluted in at a final concentration of 
102-103 CFU, having been diluted in HEPES-Hanks buffer from the overnight culture.  
10µl of the freshly made sample was used for serial dilutions and plating on Lactose 
MacConkey agar (DIFCO) containing antibiotics as previously described (also 
described below in ‘Colonization Experiments’) to obtain counts of, and differentiate 
between strains of E. coli within the population. 
Preparation of lyophilized cecal mucus 
Cecal mucus was collected via scraping from 15 mice into 30 ml of HEPES-
Hanks buffer.  The mucus collections were then centrifuged using a Sorvall™ RC6 
Plus (Thermo Scientific) at an rcf of 10,000 x g for 10 mins.  The supernatant was 
collected without disturbing the pellet, at which point the collected supernatant was 
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frozen at -80oC and the pellet was discarded.  Afterwards, the frozen supernatant was 
placed in a FreeZone Plus 12 Liter Cascade Console Freeze Dry System 
(LABCONCO) for 48 h to remove all liquid from the collected mucus.  The 
lyophilized mucus was then stored at -20°C until needed.  This was done for each in 
vitro experiment. 
Colonization experiments: 
The specifics of the streptomycin-treated mouse model used to compare the 
large intestine colonizing abilities of E. coli strains in mice have been described 
previously (34, 39, 56, 58, 60). Briefly, sets of three male CD-1 mice (5 to 8 weeks 
old) were given drinking water containing streptomycin sulfate (5 g/L) for 24 h to 
eliminate resident facultative bacteria (37). Following 18 h of starvation for food and 
water, the mice were fed 1 ml of 20% (w/v) sucrose containing 105 CFU, or 1010, CFU 
of LB broth Lennox (DIFCO) grown E. coli strains. After ingesting the bacterial 
suspension, both the food (Teklad mouse and rat diet; Harlan Laboratories, Madison, 
WI) and streptomycin-water were returned to the mice, and 1 g of feces was collected 
after 5 h, 24 h, and on odd-numbered days at the indicated times. Mice were housed 
individually in cages without bedding and were placed in clean cages at 24-h intervals. 
Individual fecal pellets were therefore no older than 24 h. Each fecal sample (1 gram) 
was homogenized in 10 ml of 1% Bacto-Tryptone (DIFCO), diluted in the same 
medium, and plated on Lactose MacConkey agar plates (DIFCO) with appropriate 
antibiotics. When appropriate, 1 ml of a fecal homogenate (which were sampled after 
the feces settled) were centrifuged at 12,000 x g, resuspended in 100µl of 1% Bacto-
Tryptone, and plated on a Lactose MacConkey agar plate (DIFCO) with appropriate 
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antibiotics. This procedure increases the sensitivity of the assay from 102 CFU/gram of 
feces to 10 CFU/gram of feces.  To distinguish the various E. coli strains in feces, 
dilutions were plated on Lactose MacConkey agar (DIFCO) containing streptomycin 
sulfate (100 µg/ml), streptomycin sulfate (100 µg/ml) and nalidixic acid (50 µg/ml), 
streptomycin sulfate (100 µg/ml) and rifampicin (50 µg/ml), or streptomycin sulfate 
(100 µg/ml) and chloramphenicol (30 µg/ml). Streptomycin sulfate, chloramphenicol, 
rifampicin, and nalidixic acid were purchased from Sigma-Aldrich (St. Louis, MO). 
All plates were incubated for 18 to 24 h at 37°C prior to counting (28). 
Fluorescent in situ Hybridization (FISH): 
In order to observe how E. coli associate locally with members of the 
microbiota in vivo, we used Fluorescent In Situ Hybridization (FISH) on cross-
sections of cecum from streptomycin-treated mice colonized with a single strain of E. 
coli.  These observations were used to compare the similar interactions in the in vitro 
system.  This was done in parallel with community analysis sequencing of bacterial 
populations in mucus samples obtained from the cecum of similarly treated mice in 
order to compare the diversity of the in vivo and in vitro models.  The mice included 
an uninoculated control set (blank 20% sucrose) and mice inoculated with E. coli 
Nissle 1917.  Samples of conventional and Nissle 1917 inoculated mice were done 
simultaneously for 6 mice, which were colonized for 10 days.  On the tenth day, mice 
were killed via CO2 and their ceca were harvested.  Three of the mice from each set 
were used for FISH, while 3 of the mice from each set were used for community 
analysis sequencing of mucus samples.  For in vitro samples, 10µl of the sample was 
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used to prepare slides for FISH and the remaining sample was used for community 
analysis sequencing. 
The cecum of a mouse designated for FISH was cut into 1-2 cm sections, 
suspended in TissueTek® O.C.T compound (Sakura Finetek USA, Inc.) and snap 
frozen in 2-methylbutane suspended in liquid nitrogen.  Sections were then stored at    
-80°C until ready for sectioning.  For sectioning, the Vibratome UltraPro 5000 
cryostat was used to cut sections at a thickness of 10µm, which were adhered to poly-
L-lysine treated slides for visualization (LabScientific, Inc).  Fixing of slides was done 
in 4% Paraformaldehyde for 1 hour at room temperature, followed by a wash in PBS 
for 10 min.  Slides were allowed to dry overnight prior to hybridization.  Fluorescent 
probes were diluted in hybridization solution consisting of 10ml of 1M Tris pH7.2, 
18ml of 5M NaCl, and 0.1g of SDS in a total volume of 100ml H20.  All slides with 
sections were treated using the FISH technique used by S. Macfarlane et al. (32), with 
hybridization of E.coli specific (5’-/5Cy3/CACCGTAGTGCCTCGTCATCA-3’) Cy-3 
probe (red) and Eubacteria specific (5’-GCTGCCTCCCGTAGGAGT/36-FAM/-3’) 
FitC probe (green) at concentrations of 5ng/µl and 25ng/µl, respectively.  These 
probes were obtained from Integrated DNA Technologies (Coralville, IA).  Briefly, 
10µl of diluted probes in hybridization solution was pipetted to each slide, which were 
then covered with a HybriSlip hybridization cover (Life Technologies, Carlsbad, CA) 
and allowed to incubate in the dark for 2 h at 50°C.  After 2 h the slides were dipped 
in a wash buffer, which is simply hybridization solution without SDS added, and then 
allowed to soak in the wash buffer for 20 min at 50°C.  Slides were then rinsed with 
distilled water and allowed to dry overnight before viewing.  Sections on poly-L-
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lysine treated slides were imaged using the Zeiss axioimager M2 imaging system with 
the Zeiss LSM 700 confocal microscope and corresponding lasers (Carl Zeiss, 
Oberkochen, Germany).  The poly-L-lysine treated slides were additionally treated 
with Vectashield (Vector Laboratories, Inc.), an antibleaching agent which helps 
prolong fluorescence for imaging.  This involves placing a small drop of Vectashield 
on the hybridized slide and then covering with a coverslip.  Allowing 30 mins at room 
temperature for the Vectashield to dry made viewing easier, but was not absolutely 
necessary. 
Isolation of cecal mucus and DNA in cecal mucus and in in vitro samples: 
For each mouse cecum being used in sampling of microbiota in the mucus, 
mucus samples were scraped and collected into 5 ml of HEPES-Hanks buffer (pH7.2).  
The in vitro samples were collected directly from overnight growth into DNA 
isolation kits.  Microbial DNA was isolated using a MO BIO PowerSoilTM DNA 
Isolation Kit. 
Sequencing: 
PCR reactions to prepare samples for sequencing were performed similarly for 
all mucus scrapings and in vitro samples.  Primers were designed to match those used 
in a study of the human gut microbiome which targeted the V4 variable region of the 
16S rRNA (62).  These primers were obtained from Integrated DNA Technologies 
(Coralville, IA) and were as follows: Forward (5’-TCG TCG GCA GCG TCA GAT 
GTG TAT AAG A-3’) and Reverse (5’-GTC TCG TGG GCT CGG AGA TGT GTA 
TAA G-3’).  Taq DNA polymerase (New England BioLabs, Ipswich, MA.) was added 
to each PCR reaction, which consisted of 25µl reactions: 2.5µl 10x Standard taq 
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Reaction Buffer (New England BioLabs Inc.), 0.5µl dNTP Solution Mix containing 10 
mM of each dNTP (New England BioLabs Inc.), 0.5µl of a 100µM solution of each 
primer, 0.5µl of the aforementioned taq DNA polymerase (New England BioLabs), all 
added to 17.5µl of DEPC treated nuclease free sterile water (Fisher Scientific).  Each 
PCR reaction began with an initial denaturation of 95°C for four min followed by a 
cycle of three steps repeated 35 times.  These were as follows: denature at 95°C for 30 
s, annealing at 55°C for 20 s, and extension at 72°C for 30 s.  Each PCR reaction 
ended with a final primer extension at 72°C for 4 min.  PCR was done using an 
Eppendorf® Mastercycler 5331 Gradient PCR Thermocycler (Westbury, NY).  PCR 
products were checked via gel electrophoresis to be sure they contained one band of 
approximately 300 bp before submission to the Rhode Island Genomics and 
Sequencing Center (RIGSC). 
Once submitted to the RIGSC, after amplicon submission, a second round of 
PCR (5 cycles) to attach Nextera (Illumina) indices and adapters was performed. 
Round 2 PCR reactions were cleaned with Agencourt Ampure XP (Beckman Coulter, 
Inc.), visualized by agarose gel electrophoresis, and selected samples were analyzed 
using the Agilent BioAnalyzer DNA1000 chip (Illumina). Qubit quantification was 
performed on all samples prior to pooling, and KAPA quantification was performed 
on the final pooled library prior to loading on the MiSeq flow cell.  The samples were 
then run on the Illumina MiSeq (Illumina RTA 1.17.28) hi-throughput sequencer. 
Sequencing analysis: 
Data output from the MiSeq comes as raw fastq files, which were then 
classified using the published Mothur pipeline version 1.33 (52).  Sequence processing 
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was aligned, cleaned of chimeric sequences, and classified using the MiSeq SOP 
(standard operating procedure) made available by the Mothur authors (52). 
The in vitro system observations: 
In order to visualize early microbial communities and how E. coli affects the 
growth of the anaerobes within mixed biofilms during early development in the in 
vitro system, FISH images were taken daily.  10µl of the overnight growth of the in 
vitro system was used to prepare and observe a slide using previously described FISH 
techniques.  Another 10µl was used for serial dilutions and plating on Lactose 
MacConkey agar (DIFCO) containing antibiotics as previously described to obtain 
counts of E. coli within the population. 
Generating crude rarefaction curves 
Crude rarefaction curves were generated using the classifications generated 
through the Mothur pipeline (52) to group the sequences at the family level.  This is 
done by randomly sampling from the families, with consideration that each family 
represents a unique member of the microbiota.  A higher abundance of a specific 
family increases the likelihood that this specific family will be sampled, thus 
experiments with a majority of its members being represented by one or two families 
will have a lower measure of diversity when compared to those with abundance spread 
across more families.  Actually having more unique families within an experiment will 
also increase the measure of diversity.  Sampling was done from 100 picks to 5000 
picks, with intervals of 100, and each was repeated 100 times. 
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Statistics 
Means and standard deviations derived from the indicated samples were 
compared by an unpaired Student's t test (P values).  A P value of > 0.05 was 
interpreted as indicating no significant difference, and a P value of < 0.05 was 
interpreted as indicating a significant difference. 
 
Results 
Initial experiments to develop the in vitro system 
The in vitro model of the gut was designed to mimic the loose mucus layer 
found in the cecum of mice.  To do this, the anaerobe populations needed to be 
protected from excessive oxygen stress.  This was accomplished by adding 3mM of 
Cleland’s reagent, a reducing agent that sequesters oxygen, thus providing the 
anaerobes with an oxygen free environment.  In addition to this, 100µg/ml of mucin 
was added to provide nutrients and an attachment site for the anaerobes to begin 
forming biofilms.  2 mg/ml of mucus was also added to provide an additional source 
of nutrients.  All of these additives were dissolved into HEPES-Hanks buffer at pH 
7.2, a buffer used for gut microbes that lacks any source of carbon or nitrogen (12).  In 
order to mimic the constant flow through and growth present in the gut, samples were 
diluted into fresh mixtures containing Cleland’s, mucin, and mucus in HEPES-Hanks 
buffer every 24 hours.  It was shown that while the microbial populations collected 
from the mouse gut could survive 1-2 days in this in vitro system (Fig. 1), a majority 
of the anaerobic population was lost after 3 days (Fig. 2).  In addition to losing 
diversity and quantity of anaerobes, E. coli that was spiked into the system grew to be 
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a majority of the sample (Fig. 2).  This contrasts what is seen in the natural 
environment inside mice, where E. coli is a minimal member of vast microbial 
biofilms (28). 
Increasing mucin concentration to 500 µg/ml improves diversity beyond day 3 
In an attempt to improve survivability of the anaerobe population, the mucin 
concentration was increased to 500 µg/ml.  The increase of mucin concentration not 
only provided anaerobes with more binding sites for initiating biofilm formation and 
food in the form of large polysaccharide chains, but also visibly increased the 
viscosity of the solution.  This increase in viscosity better mimicked the loose mucus 
of the gut, possibly providing the microbe populations with an environment more akin 
to what they prefer in their natural hosts.  This 5-fold increase in mucin concentration 
improved the in vitro system to the point where the anaerobe populations survived 
well up to day 5.  However, day 6 showed a steep loss of anaerobe populations and 
again showed the E. coli taking over as the majority (Fig. 3). 
Adding agarose increases viscosity of solution and anaerobe survival 
While increasing the concentration of mucin in the system increased the 
viscosity of the samples, they were still not quite as viscous as what is seen in the 
loose layer of mucus.  To increase the viscosity further, 0.3% agarose was added to the 
solution.  The specific amount of agarose to add was found to be the highest amount 
that could be added and still be feasibly pipetted.  This addition of agarose created an 
environment that appeared to be similar in viscosity to mucus of the loose layer.  As 
such, biofilms formed by the microbes of the gut would no longer settle to the bottom 
of the sample and could instead create networks throughout.  The agarose may also 
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have provided additional protection from oxygen, as it would be more difficult for the 
oxygen to penetrate deep into the samples.  The addition of agarose showed 
considerable improvement in the survivability of the anaerobe populations, with the 
populations remaining robust and diverse through day 6 (Fig. 4). 
Precolonizing the mouse with E.coli prior to mucus collection further improves 
anaerobe survival in the in vitro system 
In all previous experiments, E. coli was added after mucus samples were 
collected into the in vitro system.  While the addition of agarose improved the 
longevity of anaerobe populations, E. coli growth was still higher than that seen in the 
mouse beyond day 6.  The anaerobe populations also seemed to decline, albeit slowly, 
as time progressed beyond day 6.  It was possible that this was due to E. coli being 
added to the cecal mucus preparations in vitro and not in vivo.  In order to alleviate 
this, E. coli was fed to mice and allowed to colonize for 3 days prior to collection of 
the microbiota.  This allowed the E. coli to form their relationships with their preferred 
anaerobes in the natural environment of these organisms.  When E. coli was 
precolonized in mice prior to collection of the microbiota, anaerobe populations 
remained in high number and diversity through day 7 and beyond (Fig. 5, 6).  
Additionally, E. coli populations no longer grew to take over as majority members of 
the sample (Fig. 5, 6). 
Testing the necessity of the individual additives in the in vitro system 
Once the anaerobe populations were surviving beyond day 7 and the E. coli 
population was kept in check, it was necessary to test if all of the components within 
the in vitro system were actually involved in maintaining said populations.  To 
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accomplish this, growth in vitro was tested after the removal of a single component in 
parallel with a sample containing every component.  In samples sans Cleland’s reagent 
or mucin the anaerobe populations were lost within 1-2 days and the E. coli population 
grew to 108 CFU/ml (Fig. 7).  Without mucus, both the anaerobes and E. coli were lost 
(Fig. 8). 
Can the concentration of mucus be adjusted in order to control the E. coli 
population? 
With the in vitro system becoming more similar to the mouse gut, an attempt to 
control the E. coli population by adjusting the mucus concentration was tested.  
Several concentrations were tested: no mucus, 0.2mg/ml mucus, and 2mg/ml mucus 
(Fig. 8).  While 10-fold less mucus (0.2mg/ml) showed no noticeable decline in the E. 
coli population, the anaerobe population suffered considerably (Fig. 8).  Even without 
any added mucus the E. coli was able to maintain itself to some degree (1x107 
CFU/ml) (Fig. 8), likely due to the mucin not being completely purified of mono- and 
disaccharides. 
Comparing diversity of in vivo and in vitro samples 
To better compare the diversity of the in vitro system to what is seen in vivo, 
samples were taken from the in vitro Nissle 1917 pre-fed experiments after 7 days and 
used for community analysis sequencing.  The pre-fed experiments were those in 
which mice were first colonized with Nissle 1917 for 3 days prior to collecting into the 
in vitro system.  Community analysis of the in vitro samples at day 7 shows some 
diversity amongst major members of the population at the family level (Fig. 9).  A 
stacked bar plot was generated to compare the diversity in individual experiments 
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(Fig. 10).  The in vivo and in vitro samples of Nissle 1917 have similar diversity with 
representation from the same set of families except Deferribacteraceae.  However, the 
in vitro samples do have Deferribacteraceae at low levels, and are statistically similar 
when compared to the in vivo samples in terms of Deferribacteraceae using the 
student’s t-test (P > 0.05).  At the phylum level, Bacteroidetes and Firmicutes are 
comparable to what is seen in vivo, but Deferribacteres has little representation (Fig. 
11, Fig. 12).  Again, the difference in levels of Deferribacteres are not statistically 
significant between the in vivo and in vitro samples (P > 0.05). 
In order to see if the overall population was similar in terms of overall 
diversity between the in vitro and the in vivo methods, a crude rarefaction curve was 
generated for select samples of each experimental type.  When comparing 3 samples 
of E. coli Nissle 1917 in vitro to 3 samples of E. coli Nissle 1917 in vivo at the family 
level, both experimental types have similar levels of diversity (Fig. 13).  This 
similarity in diversity when comparing the entire population, as opposed to the most 
abundant organisms within the population, suggests that the in vitro system is truly 
near the mouse gut in terms of community structure. 
Using conventional mice for the in vitro system 
While streptomycin treatment is important for testing the colonization ability 
of E. coli, cultivating the unaltered gut microbiome in vitro may be of more interest.  
As such, mice that were not treated with streptomycin (thus still containing the natural 
Proteobacteria) were killed and their mucus was collected for the in vitro system.  
Slides were prepared with FISH and images were taken for 7 days.  Through day 7, in 
vitro samples showed diversity in cell morphology and E. coli labeled cells were seen 
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within mixed biofilms (Fig. 14).  Community analysis of the samples at day 7 in vitro 
showed diversity amongst major members of the population at the family level (Fig. 
15, Fig. 16), with members present within the in vitro system being comparable to 
those seen in in vivo samples, although differences between the in vitro and in vivo 
samples were seen in the Bacteroideaceae (P < 0.0001), Deferribacteraceae (P < 
0.001), and Lachnospiraceae (P < 0.001).  At the phylum level, Bacteroidetes were 
more abundant relative to Firmicutes in the conventional in vitro samples compared to 
what was seen in the in vivo samples, and Deferribacteres had little representation in 
vitro (Fig. 17, Fig. 18).  The differences seen between each phylum; Bacteroidetes, 
Deferribacteres, and Firmicutes, are statistically significant (P < 0.001 for each).   The 
loss of Firmicutes can be traced to the Lachnospiraceae family, which has a high 
abundance in the samples taken directly from mice but is considerably lower in the in 
vitro samples (P < 0.01) (Fig. 15). 
In order to see if the overall population was similar in terms of overall 
diversity between the in vitro and the in vivo methods, a crude rarefaction curve was 
generated for select samples of each experimental type.  When comparing 3 
conventional in vitro samples to 3 conventional in vivo samples at the family level, 
both experimental types have similar levels of diversity (Fig. 19).  It is also apparent 
that conventional samples are more diverse than Nissle 1917 samples, likely due to the 
treatment of streptomycin prior to colonization.  This similarity in diversity when 
comparing the entire population, as opposed to the most abundant organisms within 
the population, suggests that the in vitro system is truly near the mouse gut in terms of 
community structure. 
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Testing the ability of pre-colonized strains to prevent later colonization with the 
same strain 
When mice are pre-colonized with an E. coli strain, they are resistant to 
subsequent intestinal colonization by the same strain (2, 27).  This is likely because 
the niches usually taken by these E. coli strains are already filled by the preexisting 
population.  To test if this is true in the in vitro system, mice were pre-colonized with 
either Nissle 1917 or MG1655 and then collected into the in vitro system after 3 days 
of colonization.  After 7 days in the in vitro system, the identical strain was spiked in 
at 103 CFU/ml (Nissle 1917 for Nissle 1917, and MG1655 for MG1655).  As 
expected, pre-colonized Nissle 1917 prevented the late fed Nissle 1917 from growing 
up (Fig. 20), and pre-colonized MG1655 prevented late fed MG1655 from growing to 
higher numbers (Fig. 21). 
Testing the colonization ability of Nissle vs MG1655 in vitro 
Once the populations were maintained, it was important to test if the in vitro 
system was truly mimicking the mouse gut.  To do this, competition between E. coli 
strains that had been previously tested in mouse colonization experiments were used.  
Mice were initially inoculated with the Nissle 1917 for 3 days, and then the microbiota 
was collected into the in vitro system.  The populations were sustained for 7 days, and 
then MG1655 was spiked in at 105 CFU/ml.  In vivo, mice fed Nissle 1917 early and 
MG1655 late show no direct competition between the strains, i.e. as Nissle 1917 and 
MG1655 can outcompete one another on one or more sugars, they are able to co-
colonize in vivo without issue (17).  In vitro, MG1655 was not able to co-colonize 
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with Nissle 1917, and dropped below detectable numbers 4 days after being spiked in 
(Fig. 22).  However, the reverse showed more promising results.  When MG1655 is 
fed early and Nissle 1917 fed late in mice, they are able to co-colonize as they are not 
in direct competition (17).  This proved to be true in vitro as well, when MG1655 was 
fed early to mice before collection and Nissle 1917 was spiked in at day 7 in vitro 
(Fig. 23). 
 In the presence of E. coli Nissle 1917, E. coli EDL933 uses gluconeogenesis to 
colonize the in vitro system as it does in vivo.  
In vivo, EDL933 uses gluconeogenesis when co-colonized with Nissle 1917 in 
order to maintain itself within the gut (51).  This is known because when a mouse is 
pre-colonized with Nissle 1917 for 10 days and then fed 105 CFU each of EDL933 
wildtype and EDL933 ppsA pckA (a mutant unable to grow on gluconeogenic nurients 
“below” phosphoenolpyruvate) the mutant EDL933 is unable to compete and falls to 
undetectable numbers (51).   
In order to test if the in vitro system mimicked the mouse gut, this experiment 
was repeated in vitro.  To do this, Nissle 1917 was pre-colonized in mice at 105 
CFU/ml for 10 days, and EDL933 and EDL933 ppsA- pckA- were spiked into the in 
vitro system at 103 CFU/ml one day after collection.  EDL933 wildtype and the 
EDL933 ppsA- pckA- mutant were spiked at 103 CFU/ml because they were spiked 
into a fresh dilution of the microbiota, which would leave Nissle 1917 at 
approximately 107 CFU/ml.  This would give a difference of 104 CFU/ml, the same 
difference when fed late to mice.  When the in vitro experiment was performed with 
Nissle 1917 pre-colonized for 10 days after which the wildtype EDL933 and the 
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EDL933 ppsA- pckA- mutant were spiked into the in vitro system one day after 
collection, it mimicked the mouse experiments (Fig. 24), i.e Nissle 1917 colonized at 
approximately 108 CFU/ml, EDL933 wildtype maintained itself at approximately 104 
CFU/ml, and EDL933 ppsA- pckA- fell below detectable numbers by day 4. 
EDL933 vs. EDL933 ppsA-pckA- 
In mice, EDL933 and EDL933 ppsA-pckA- can co-colonize equally well in the 
absence of Nissle 1917 (51), suggesting that in the absence of Nissle 1917, EDL933 is 
not forced to use gluconeogenic substrates in order to compete and thus the non-
gluconeogenic mutant is not at a disadvantage.  This was tested in the in vitro system 
by collecting mucus from streptomycin treated mice for collection into the in vitro 
solution, and EDL933 and EDL933 ppsA- pckA- were spiked into the in vitro system 
at 103 CFU/ml 1 day after collection.  Initially, both strains were able to grow to 
similar counts at approximately 107 CFU/ml, but eventually the EDL933 ppsA- pckA- 
mutant began to drop.  Unlike in mice, the EDL933 and EDL933 ppsA- pckA- were 
unable to co-colonize, with the EDL933 ppsA- pckA- mutant falling below detectable 
numbers after 10 days in vitro (Fig. 25). 
Discussion 
In this study, an in vitro method for cultivating the microbiota of the 
mammalian gut was developed.  This method will allow us to study the relationship 
between E. coli and the rest of the gut microbiota with more control and accessibility 
than in in vivo models, such as the streptomycin treated mouse model.  While other in 
vitro methods have been developed to study biofilms from various environments, this 
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novel method was designed specifically for the gut microbiota, and it was kept as 
simple and user friendly as possible. 
During the development of this in vitro method, samples of growth from the in 
vitro system were submitted for community analysis sequencing of the microbial 
community.  These samples were taken from day 7 in vitro samples of Nissle 1917 
and another set of samples in which the cecal mucus of untreated mice (not colonized 
with E. coli or treated with streptomycin) were collected into the in vitro system 
(labeled “conventional”).  The in vitro samples were compared to in vivo samples 
prepared similarly, by either pre-colonizing mice with Nissle 1917 for 10 days, at 
which point the mice were killed and mucus was collected, or in vivo samples that 
were collected from untreated (conventional) mice. 
By comparing the Nissle 1917 in vivo and in vitro samples at the phylum level 
it can be seen that a similar spread of major members of the population can survive 
within the in vitro system, but a loss in the relative abundance of certain organisms 
occurs (Fig. 11, Fig. 12).  While the abundance of Firmicutes and Bacteroidetes are 
comparable between the in vivo and in vitro methods, Deferribacteres seems to have 
trouble surviving the in vitro system.  Deferribacteres is not completely lost, as it is 
present at lower levels in these samples but still exists. 
At the family level, both Nissle 1917 in vitro and in vivo samples have 
representatives from the same families (Fig. 9, Fig. 10).  Deferribacteriaceae has 
relatively low levels of representation in the in vitro system, but again is still present.  
However, the loss of relative abundance of these major members does not coincide 
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with an overall loss of diversity as shown by (Fig. 13) with both in vivo and in vitro 
samples of Nissle 1917 showing similar levels of diversity.  
When comparing phyla of the conventional samples, in vitro to in vivo, a 
similar loss of Deferribacteres is seen (Fig. 17).  Again, this loss is not a complete 
clearing of Deferribacteres but rather a loss in the relative abundance of the organism.  
The diversity of major members at the family level is much higher in the conventional 
samples (in vitro and in vivo), with a larger spread across various families than that 
seen in the Nissle 1917 samples (Fig. 15).  Furthermore, the diversity of the individual 
conventional samples was much more robust than the Nissle 1917 samples both in 
vivo and in vitro, showing higher diversity in a crude rarefaction curve (Fig. 19).  This 
shows that the conventional samples in vitro are truly diverse, and also mimic the in 
vivo conventional samples in level of diversity. 
Deferribacteres is a relatively recently described lineage, but one genus of 
Deferribacteres, Mucispirillum, has been identified as existing in the mammalian gut 
and being able to degrade mucin (22, 49).  Interestingly, Deferribacteres were lower in 
many of the in vitro samples, possibly due to the low concentration of mucin which 
Mucispirillum utilizes for growth.  Lachnospiraceae is a member of the Firmicutes that 
is able to produce butyric acid and has been previously linked to obesity (36).  
Ruminococcaceae, another Firmicutes, has been previously shown to exist in the gut, 
but is difficult to classify and is often a mistakenly identified Lachnospiraceae (31).  
Paenibacillaceae is a Firmicutes with species that exist as plant growth promoting 
rhizobacteria and may have been introduced through the feed given to mice (5).  The 
s24-7 family is a member of the Bacteroidetes that has been found to inhabit the 
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mouse gut, but little else has been described (19).  Another bacteroidetes, 
Porphyromonadaceae, has been previously shown to occasionally inhabit the gut, but 
more often resides in oral cavities as a pathogen (40).  Rikanellaceae is another 
Bacteroidetes that has a recently reclassified member, Alistepes putredinis which was 
previously classified as a Bacteroides and shows similarities with Bacteroides fragilis 
and members of Porphyromonadaceae (48).  Bacteroidaceae contains the Bacteroides 
genus, which can use simple sugars when available, but use glycans as a main source 
of energy (33). 
In order to show that the novel in vitro system could mimic the mouse in terms 
of colonization ability, a series of tests were done using the new in vitro system in 
parallel to those done with mice.  Early attempts at comparing in vivo colonization 
experiments to those done in vitro proved that the system was not quite identical to the 
mouse, but similarities were present.  When mice are pre-colonized with an E. coli 
strain, they are resistant to subsequent intestinal colonization by the same strain (2, 
27).  This was tested in the in vitro method with Nissle 1917 and MG1655, and this 
colonization resistance was also seen in the in vitro system (Fig. 20, Fig. 21).  
However, it was previously shown that colonization by a different strain would be 
possible, so long as the pre-fed strain and the new strain were not in direct competition 
for sugars (17).  This was again tested in vitro using Nissle 1917 and MG1655.  When 
MG1655 was pre-fed and Nissle 1917 was added late, Nissle 1917 was able to grow 
up with MG1655 as is seen in mice (Fig. 23).  In contrast, when Nissle 1917 was pre-
fed and MG1655 was added late, MG1655 was unable to grow up against Nissle 1917 
and was eventually washed out of the system (Fig. 22).  This may be due to the system 
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developing early with Nissle 1917, thus promoting an anaerobe population that is 
more preferential for the growth of Nissle 1917. If said population only produced 
mono- and disaccharides that resulted in Nissle 1917 and MG1655 growing in direct 
competition, with Nissle 1917 being able to grow faster on the supplied sugars, 
MG1655 would be unable to colonize and would eventually fall below detectable 
numbers.  It is also possible that Nissle 1917 may use up all the nutrients in vitro, but 
not in vivo, as nutrients are likely more limited in the in vitro system.  Another 
possibility is that the flow through of the gut is important for either directly keeping 
the population of Nissle 1917 in check, or for keeping certain key anaerobes in check 
that give Nissle 1917 a competitive edge over MG1655.  This same effect could be 
carried out by the innate immune system of the gut.  Considering that when MG1655 
was pre-fed and Nissle 1917 was added late both were able to grow and colonize 
equally well, it is unlikely to be due to population control via flow or the innate 
immune system.  It is important to note that as these experiments were done early in 
the development of the system, mice were only pre-colonized for 3 days prior to being 
moved into the in vitro system, and then allowed a further 7 days for the pre-colonized 
E. coli strain to settle before spiking in the competing strain.  Perhaps allowing the 
pre-colonized strain to remain in mice for the full 10 days prior to collection into the 
in vitro system could improve these colonizations.  
Another competition chosen was Nissle 1917 fed early against EDL 933 
wildtype and EDL933 ppsA- pckA-.  EDL933 is an enterohemorrhagic E. coli 
(EHEC), and the mutant EDL933 ppsA- pckA- is unable to utilize gluconeogenic 
substrates (51).  In mice, Nissle 1917 keeps EDL933 wildtype from colonizing higher 
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than 106 CFU/gfeces and EDL933 ppsA- pckA- is unable to colonize, falling below 
detectable numbers after only a few days (51).  In the mice, late fed strains are fed 10 
days after the pre-colonizing strain.  To better mimic this, an experiment was done in 
which the pre-colonizing strain was allowed to remain in the mice for 10 days prior to 
collecting into the in vitro system.  In this experiment, Nissle 1917 was fed to the mice 
while the EDL 933 and EDL 933 ppsA- pckA- strains were added later to the in vitro 
system.  This experiment mimicked the mouse experiment, showing that the in vitro 
method was beginning to more mimic the mouse (Fig. 24). 
A final experiment was done to see how closely the in vitro system mimicked 
the mouse gut in terms of colonization ability.  In the absence of Nissle 1917, EDL933 
and EDL933 ppsA- pckA- are able to colonize equally well when initially colonized at 
the same concentration (51).  This was tested in the in vitro system by collecting 
mucus from streptomycin treated mice and spiking EDL933 and EDL933 ppsA- pckA- 
into the collection solution.  While the experiment went well early on, with both 
strains growing to 107 CFU/ml, an eventual loss in EDL933 ppsA- pckA- shows that 
the system is not yet perfect (Fig. 25).  It is likely that the lower concentration of 
mucin and mucus in the in vitro system results in less mono- and disaccharides being 
made available by the anaerobe population for the EDL933 and EDL933 ppsA- pckA- 
strains to grow without the use of gluconeogenic substrates.  Through limitation of 
glycolytic substrates, this forced gluconeogenic shift would give the wildtype EDL933 
a distinct advantage over EDL933 ppsA- pckA-, as the mutant cannot use 
gluconeogenesis. 
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At this point the novel in vitro model designed to mimic the mouse gut is 
capable of cultivating the microbiota of the gut, but is only able to mimic certain 
colonization experiments of E. coli competitions.  In terms of mimicking the diversity 
of the gut, only the relative abundance of certain members of the community is 
affected by growth in the in vitro system.  This may be overcome by slight alterations 
to the system, such as an increase in the concentrations of mucin and/or mucus in 
order to provide more nutrients to these populations.  This may also have an effect on 
the colonization experiments, as the key factor in these competitions is the availability 
of specific substrates within specific niches.  Even continued streptomycin treatment 
within the in vitro system must be considered, as at this point streptomycin treatment 
stops once removed from the mouse.  The streptomycin may be important for 
maintaining a clear niche for some of these competing strains to move into, thus 
resulting in the loss of a competitive advantage by not continuing streptomycin 
treatment within the in vitro system.  Furthermore, the early competitions involving 
Nissle 1917 and MG1655 may be improved if the pre-colonizing strain is allowed to 
remain in mice for a full 10 days prior to collection.  The innate host immune system 
may also be key in maintaining a balanced ecosystem within the gut (10, 13, 44, 54), 
and as such may be important for the development of available niches to colonizing E. 
coli strains.  Thus, while the system is useful for observing the microbial community 
of the mouse gut and the interactions with a single colonizing E. coli strain, the novel 
in vitro gut model must be further improved in order to assess colonization ability of 
individual E. coli strains. 
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Table 1. Bacterial strains 
E. coli strain Genotype/phenotype Designation in 
text 
Source or 
reference 
MG1655 StrR Spontaneous streptomycin 
resistant mutant of MG1655 
MG1655 6 
Nissle 1917 StrR 
NalR 
Spontaneous naladixic acid 
resistant mutant of Nissle 
1917 StrR 
Nissle 1917 24, 44 
EDL933 StrR RifR Spontaneous streptomycin 
resistant mutant of EDL933 
EDL933 38 
EDL933 StrR 
ΔppsA ΔpckA::cam 
 
Double deletion mutant of 
EDL933 Strr, carrying cat in 
the pckA deletion and 
retaining the pO157 
virulence plasmid 
EDL933 ppsA-
pckA- mutant 
42, 32 
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Table 2. Primers 
Primer designation Sequence 
E.coli specific Cy-3 probe (red) 
used for FISH 
5’-/5Cy3/CACCGTAGTGCCTCGTCATCA-3’ 
Eubacteria FitC probe (green) 
used for FISH 
5’-GCTGCCTCCCGTAGGAGT/36-FAM/-3’ 
16S V4 forward used for 
community analysis sequencing 
5’-TCG TCG GCA GCG TCA GAT GTG TAT 
AAG A-3’  
16S V4 reverse used for 
community analysis sequencing 
5’-GTC TCG TGG GCT CGG AGA TGT GTA 
TAA G-3’ 
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Fig. 1 FISH images of the early in vitro system with (top) and without (bottom) E. coli 
taken from day 0 samples.  Both populations are intact.  Red bacterial cells represent 
E. coli labeled by the Cy3-probe, while green bacterial cells represent all Eubacteria 
labeled by the FitC-probe. 
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Fig. 2 FISH images of the early in vitro system with (top) and without (bottom) E. coli 
taken from day 3 samples.  When E. coli is present, it grows out of proportion and 
takes over the system, and in both systems the rest of the population is mostly lost.  
Red bacterial cells represent E. coli labeled by the Cy3-probe, while green bacterial 
cells represent all Eubacteria labeled by the FitC-probe. 
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Fig. 3 FISH images of the in vitro system with mucin concentration increased to 
500ug/ml taken from day 5 (top) and day 6 (bottom) samples.  While increasing the 
mucin concentration improved the longevity of the system, most of the population is 
still lost beyond day 5.  Red bacterial cells represent E. coli labeled by the Cy3-probe, 
while green bacterial cells represent all Eubacteria labeled by the FitC-probe. 
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Fig. 4 FISH images of the in vitro system after adding 0.3% agarose without E. coli 
taken from day 6 samples (top) and before adding agarose taken from day 6 samples 
(bottom).  Even without the E. coli present, agarose has improved the survivability of 
the population within the in vitro system.  Red bacterial cells represent E. coli labeled 
by the Cy3-probe, while green bacterial cells represent all Eubacteria labeled by the 
FitC-probe. 
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Fig. 5 FISH image taken from in vitro experiment in which mice were precolonized 
with E. coli for 3 days prior to collection into the in vitro system, taken from day 7 in 
vitro samples.  The E. coli is no longer growing to take over the entire population, and 
the rest of the organisms are able to survive and form biofilm communities.  Red 
bacterial cells represent E. coli labeled by the Cy3-probe, while green bacterial cells 
represent all Eubacteria labeled by the FitC-probe. 
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Fig. 6 Comparison of a FISH imaged biofilm of in vivo samples from a mouse 
colonized with Nissle 1917 for 10 days (left) and in vitro samples in which a mouse 
was precolonized with Nissle 1917 for 3 days prior to being collected into the in vitro 
system, taken from day 7 in vitro samples (right). 
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Fig. 7 FISH images taken from in vitro samples on day 7 in which either no mucin 
(above) or no Cleland’s reagent (below) was added.  These images show the 
importance of the mucin and Cleland’s reagent in preserving the community within 
the in vitro system.  Red bacterial cells represent E. coli labeled by the Cy3-probe, 
while green bacterial cells represent all Eubacteria labeled by the FitC-probe. 
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Fig. 8 7 FISH images taken from in vitro samples on day 7 in which either no mucus 
(above) or only 0.2 mg/ml mucus (below) was added.  Decreasing the mucus 
concentration results in a loss of a majority of the population, with E. coli taking over 
as the majority of surviving cells.  Red bacterial cells represent E. coli labeled by the 
Cy3-probe, while green bacterial cells represent all Eubacteria labeled by the FitC-
probe. 
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Fig. 9 Bar plot showing relative abundance of major families in mice colonized with 
Nissle 1917 for 10 days (green) and in vitro samples in which mice were precolonized 
with E. coli for 3 days prior to collection into the in vitro system, taken from day 7 in 
vitro samples.  While there seems to be a difference in terms of s24-7 and 
Deferribacteracaea, the differences are not statistically relevant and both mice and in 
vitro samples have similar levels of representation from the same major families.  
Error bars indicate standard error of the mean. 
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Fig. 10 Stacked bar plot showing relative abundance of Nissle 1917 in vivo (left) and 
in vitro (right) at the family level.  The stacked bars are showing the same data as is 
seen in the relative abundance graphs, but separates the individual samples to better 
highlight the variation amongst hosts. 
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Fig. 11 Bar plot showing relative abundance of major phyla in mice colonized with 
Nissle 1917 for 10 days (green) and in vitro samples in which mice were precolonized 
with E. coli for 3 days prior to collection into the in vitro system, taken from day 7 in 
vitro samples.  None of the differences seen are enough to be statistically significant 
(P > 0.05).  Error bars indicate standard error of the mean. 
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Fig. 12 Stacked bar plot showing relative abundance of Nissle 1917 in vivo (left) and 
in vitro (right) at the phylum level.  The stacked bars are showing the same data as is 
seen in the relative abundance graphs, but separates the individual samples to better 
highlight the variation amongst hosts. 
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Fig. 13 Crude rarefaction curves of Nissle 1917 samples used to compare richness of 
diversity in vitro (top) and in vivo (bottom). 
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Fig. 14 FISH image of an in vitro sample in which the cecal mucus of an untreated 
“conventional” mouse was collected into the in vitro system, taken from day 7 in vitro 
sample.  Diversity in the cell morphologies can be seen amongst the organisms 
present.  Red bacterial cells represent E. coli labeled by the Cy3-probe, while green 
bacterial cells represent all Eubacteria labeled by the FitC-probe. 
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Fig. 15 Bar plot showing relative abundance of major families in untreated 
“conventional” mice (white) and in vitro samples in which untreated “conventional” 
mice were collected into the in vitro system (blue), taken from day 7 in vitro samples.  
Error bars indicate standard error of the mean.  Differences between the in vitro and in 
vivo samples were seen in the Bacteroideaceae (P < 0.0001), Deferribacteraceae (P < 
0.001), and Lachnospiraceae (P < 0.001). 
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Fig. 16 Stacked bar plot showing relative abundance of conventional in vivo (left) and 
in vitro (right) at the family level.  The stacked bars are showing the same data as is 
seen in the relative abundance graphs, but separates the individual samples to better 
highlight the variation amongst hosts. 
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Fig. 17 Bar plot showing relative abundance of major phyla in untreated mice (white) 
and in vitro samples in which untreated mice collected into the in vitro system (blue), 
taken from day 7 in vitro samples.  Error bars indicate standard error of the mean.  At 
the phylum level, Bacteroidetes were more abundant relative to Firmicutes in the 
conventional in vitro samples compared to what was seen in the in vivo samples, and 
Deferribacteres had little representation in vitro.  The differences seen between each 
phylum; Bacteroidetes, Deferribacteres, and Firmicutes, are statistically significant (P 
< 0.001 for each). 
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Fig. 18 Stacked bar plot showing relative abundance of conventional in vivo (left) and 
in vitro (right) at the phylum level.  The stacked bars are showing the same data as is 
seen in the relative abundance graphs, but separates the individual samples to better 
highlight the variation amongst hosts. 
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Fig. 19 Crude rarefaction curves of conventional samples used to compare richness of 
diversity in vitro (top) and in vivo (bottom). 
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Fig. 20 Competition experiments of Nissle 1917 early vs Nissle 1917 late: in vivo 
(top) and in vitro (bottom).  This shows that colonization resistance is seen in vitro just 
as it is seen in mice. 
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Fig. 21 Competition experiments of MG1655 early vs MG1655 late: in vivo (top) and 
in vitro (bottom).  This shows that colonization resistance is seen in vitro just as it is 
seen in mice. 
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Fig. 22 Competition experiments of Nissle 1917 early vs MG1655 late: in vivo (top) 
and in vitro (bottom).  This shows that not all competitions are mimicked perfectly in 
the in vitro system, possibly due to limitation of nutrients. 
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Fig. 23 Competition experiments of MG1655 early vs Nissle 1917 late: in vivo (top) 
and in vitro (bottom).  This shows that competitions in which MG1655 is fed early and 
Nissle 1917 is fed or spiked in late are similar in mice and in vitro. 
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Fig. 24 Competition experiments of Nissle 1917 early vs EDL933 wildtype and 
EDL933 pckA-ppsA- late: in vivo (top) and in vitro (bottom).  Another competition in 
which the in vitro system mimics what is seen in mice, as the EDL933 gluconeogenic 
mutant cannot compete and falls out of the system while the wildtype is maintained. 
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Fig. 25 Competition experiments of EDL933 wildtype vs EDL933 pckA-ppsA-: in vivo 
(top) and in vitro (bottom).  This competition shows that the in vitro system is unable 
to mimic the mouse perfectly as EDL933 does not switch to gluconeogenic substrates 
in mice that were not pre-colonized with Nissle 1917, but does switch in the in vitro 
system.  Again likely due to limitation of nutrients. 
